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ABSTRACT
Mediation analysis has been undertaken pervasively in practice. The primary goal of
this analysis is to study whether the effect of an exposure on an outcome of interest is
mediated by some intermediate factors such as epigenetic variants and metabolomic
biomarkers. In this dissertation I develop new statistical methods to address some of
statistical and scientific challenges arising from causal mediation pathway analyses.
Chapter II develops a simultaneous likelihood ratio (LR) test in the presence of
multiple mediators. Statistical inference on the joint mediation effect is challenging
due to the involvement of composite null hypotheses with a large number of parameter
configurations. With an application of the Lagrange Multiplier approach, simulta-
neous LR test utilizes a block coordinate descent algorithm to solve the constrained
likelihood under the irregular null parameter space. I establish the asymptotic null
distribution and examine the finite-sample performance of the proposed joint test
statistic via extensive simulations with comparisons to existing tests. The simulation
results show that the joint testing method controls type I error properly and in gen-
eral provides better power than existing tests. I apply this new method to investigate
whether a group of glucose metabolites and acetylamino acids mediate the effect of
nutrient intakes on insulin resistance.
Chapter III presents a unified framework of generalized structural equation models
(GSEMs) for mediation analyses with data of mixed types to address practical needs
in the analysis of biomedical data. This new class of models accommodates contin-
uous, categorical, count variables. Using the Fréchet’s construction of multivariate
xii
distributions, I formulate GSEM as a hierarchical model consisting of (i) a Gaussian
copula dependence model to characterize a directed acyclic graph (DAG) relationship
among outcome variable, mediator and exposure variable, and (ii) generalized linear
models (GLMs) to adjust confounding factors in marginal distributions. This new
framework provides valid joint probability distributions and well-defined mediation
effects for interpretation. I develop a pseudo-maximum likelihood estimation for var-
ious scenarios of mixed data types. I illustrate this new methodology via a dataset
collected from a cohort study in environmental health sciences, where I study whether
the tempo of reaching infancy BMI peak, an important early life growth milestone
that may be measured as either a continuous variable or a binary variable (delay
or not), may mediate the association between prenatal exposure to phthalates and
pubertal health outcomes.
Chapter IV concerns a conceptual framework of generalized direct and indirect
effects to relax the current definitions of causal mediation effects in the presence of
categorical intervention or categorical exposure. I utilize the latent variable presenta-
tion to describe the role of a categorical “action” in a causal study. Specially, I focus
on two important types of models, namely the effective dose model and the latent
exposure model. I demonstrate that the proposed generalized direct and indirect ef-
fects are more desirable to quantify and interpret direct and indirect effects than the
conventional approach. I develop maximum likelihood estimation for the model pa-
rameters, and examine numerically the performance of the estimation via simulation
studies. Also, I illustrate this new causal mediation paradigm via a randomized trial
from the ELEMENT study where I investigate whether the association of mother’s
calcium supplementation on offspring birth weight is mediated by mother’s blood lead





In many disciplines such as Psychology, Sociology, Epidemiology, Environmental
Health Sciences, Political Science, researchers aim to understand certain causal me-
diation mechanisms through which exposure variables affect outcome variables of
interest. Mediators are typically referred to as some intermediate variables that lie in
causal pathways between exposure and outcomes. For instance, obesity or overweight
is deemed as the primary cause for insulin resistance, a health condition that human
body cannot operate insulin secretion properly and consequently, fails to effectively
move glucose from bloodstreams to cells. In a cohort study “Early Life Exposures in
Mexico to ENvironmental Toxicants” (ELEMENT), investigators hypothesized that
an individual’s metabolomics may mediate the relationship between nutrient intakes
and insulin resistance (LaBarre et al., 2020). Figure 1.1 illustrates a hypothesized
causal mediation mechanism involves exposure (i.e.,nutrient intakes), mediator (i.e.,
metabolome) and outcome (i.e., insulin resistance), in addition to some confounding
factors that are not shown for the sake of simplicity. This figure is also known as
directed acyclic graph (DAG), which presents a scientific hypothesis based on certain
directed relationships via directed edges. In a causal mediation framework, the ex-
posure variable (e.g., nutrient intake) is often referred to a variable that may vary
1
Figure 1.1: Hypothesized causal associations among food intakes, metabolome and
insulin resistance.
under different conditions, such as nutrient intakes that measure the consumption
of food (fats and carbohydrates), whose amount varies for each participant. Other
examples of exposure include concentration levels of a toxic agent in environmental
health sciences and a drug treatment in a randomized control trial.
The ELEMENT cohort study is a multi-institutional, internationally teamed project
which was initiated in early 1990s. It recruited three birth cohorts of 1,643 child-
mother pairs during pregnancy or delivery from maternity hospitals in Mexico city,
between 1993 and 2004 (Perng et al., 2019). The ELEMENT cohorts have since
developed more than ten individual projects to answer some important questions re-
lated to the Developmental Origins of Health and Disease (DOHaD)’ hypothesis in
environmental health sciences. The main study aims are to understand how environ-
mental toxicants, such as phthalates, chemicals and metals affect maternal and child
health. A wide array of data were collected from mothers and children, including
their dietary intakes, anthropometry, prenatal exposures, fasting metabolites, and
DNA mythelation and so on.
In a DAG, causal effects pertain to three primary quantities, termed as total
effect (TE), direct effect (DE) and indirect effect (IE). TE of an exposure on an
outcome describes the total amount of changes of the outcome caused by the changes
of the exposure. In the literature, TE usually is decomposed into two component (or
effects), DE and IE. DE is the effect that is only explained by the exposure, while IE
2
is the effect that manifests through mediators. Sometimes, IE is also called mediation
effect. In our motivating example, DE is the change in the level of insulin resistance
when nutrient intakes change in which metabolome were held fixed. IE expresses the
change in the level of insulin resistance resulted from the change of the metabolome
under the condition of fixed exposure. A key objective in the mediation analysis is to
assess the three types of effects, TE, DE and IE, especially the mediation effect IE.
In such analysis, many methodological challenges arise, including (i) the presence of
non-normal data such as discrete, count, survival variables; (ii) there are potentially
many latent variables as a DAG is too simple to represent the underlying causal
mediation pathways; (iii) the existence of unmeasured confounding factors; (iv) the
presence of potential multiple or even high-dimensional correlated mediators, just
name a few. Some of these methodological challenges motivated the development of
statistical methods in this dissertation.
Specifically, this dissertation is motivated by three scientific research questions of
interest:
• First, we are interested in understanding if the associations of dietary intakes
on the insulin resistance is mediated through a cluster of glucose metabolites
and acetylamino acids.
• Second, we are interested in finding how, and to what extent, a delay of reaching
the BMI infancy peak on time or not may affect the associations of prenatal
phthalate exposures on children’s health outcomes during peripuberty.
• Lastly, we investigate if the associations of mother’s calcium intakes in a cal-
cium supplementation randomized control trial on birth weight is mediated by
mother’s blood lead level during third trimester.
3
1.2 Existing Work
The classical mediation analysis approach, first proposed by Baron and Kenny (Baron
and Kenny , 1986), is implemented under the linear structural equation models (SEM,
(Ullman and Bentler , 2003)) with multivariate normally distributed data. Recently,
utilizing the counterfactual (potential) outcome framework in the causal inference
literature (Robins and Greenland , 1992; Pearl , 2013; VanderWeele and Vansteelandt ,
2014), the classical mediation approach has been extended to represent a causal me-
diation pathway via DAG under a certain scientific hypothesis. With a few extra
assumptions on causality, the notions of DE and IE have been extended to natural
direct effect (NDE), and natural indirect effect (NIE), which allows for a decomposi-
tion of the total effect under the settings with exposure-mediator interactions and/or
settings with non-linearity (VanderWeele and Vansteelandt , 2009; Vansteelandt and
VanderWeele, 2012; Pearl , 2013; Valeri and VanderWeele, 2013).
Since decades ago, most of the mediation analyses are only able to quantify and
test one mediator in a DAG. MacKinnon et al. (MacKinnon et al., 2002) summa-
rize and compare fourteen different approaches to mediation analyses, including joint
significance test(MacKinnon et al., 2002), product test based on normality assump-
tion (Sobel , 1982), and bootstrap test (Bollen and Stine, 1990). The challenge of
the hypothesis testing for mediation effect lies on the composite nature of the null
hypothesis, leading to conservative type I error. This remains an unsolved problem.
With the advent of advanced omics technologies, there has been an increasing
need in analyzing the mediation effects in biomedical applications with multiple or
even high-dimensional mediators, such as in epigenetic studies. In such settings,
many works aim to decompose total effect into different path-specific effects involv-
ing multiple mediators (Daniel et al., 2015; Zhao et al., 2020). Other works aim
to select the mediation pathways under high-dimensional settings (Zhao and Luo,
2016; Song et al., 2020). Other procedures of causal mediator selection (Barfield
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et al., 2017; Huang et al., 2019; Dai et al., 2020; Liu et al., 2021) perform univariate
analyses of mediators one by one, without acknowledging the fact that mediators
under investigation are intrinsically correlated. These approaches assume that medi-
ators are conditionally independent given both exposures and confounders, which is
an unrealistic assumption. As noted in the literature, if correlations among media-
tors are present, analyzing their mediation effects one at a time would usually lead
to biased effect estimates due to over-counted pathways and the violation of model
assumptions (VanderWeele and Vansteelandt , 2014; VanderWeele, 2015). Thus, it
is of critical importance to analyze a set of multiple mediators jointly, and test for
their joint mediation effect simultaneously. Huang et al (Huang and Pan, 2016; Huang
et al., 2018) proposed two methods: Product Test based on Normal Product distribu-
tion (PT-NP), and Product Test based on Normality (PT-N) that test the mediation
effect with multiple mediators. Although both methods work numerically well in
simulations, there is a lack of rigorous theoretical understanding on the justification
for several approximations taken in the derivations. This motivates the research of
Chapter II, where I developed a likelihood ratio test for mediation effect with multiple
mediators.
Non-normal data are frequently encountered in a mediation analysis, including
one-dimensional dichotomous mediator (Albert and Nelson, 2011), one-dimensional
dichotomous outcome (VanderWeele and Vansteelandt , 2010), and one-dimensional
time-to-event outcome (VanderWeele, 2011). Due to the different types of non-normal
data, different assumptions are required to fulfill the effect decomposition and to per-
form parameter estimation. There lacks a unified approach that conducts mediation
analysis of exposure, mediator and outcome with different data types collectively.
This motivates the research of Chapter III, where I proposed a unified framework via
copula dependence models to analyze the data with mixed types in the mediation
analysis.
5
Mediation analyses based on DAG may be too simple to represent the underlying
causal mediation pathway. One challenge pertains to the influence of underlying
latent variables. For example, Derkach et al. (Derkach et al., 2019) considered a
setting where a group of unmeasured variables are influenced by the exposure and
would in turn impact mediators and outcome. However, little methodological work
has been done to deal with potential latent exposure variables in mediation analyses.
This motivates the research of Chapter IV, where I developed two models with latent
exposure variables, and proposed generalized natural direct effect and generalized
natural indirect effect.
1.3 A Summary of New Contributions
This dissertation develops new statistical methodologies to address the aforemen-
tioned limitations and challenges.
Chapter II develops a likelihood ratio (LR) test for multi-dimensional mediation ef-
fect that accounts for causally related mediators via the Lagrange Multiplier method.
We decompose the parameter space under the composite null hypothesis into two
disjoint spaces, and derive asymptotic null distributions of the test statistics in each
sub-space. We develop a block coordinate descent algorithm to obtain the constrained
maximum likelihood estimate, and perform extensive simulations to compare the LR
method with two existing alternatives of PT-NP and PT-N. The simulation results
demonstrate that our method can control type I error rate properly and provides
higher or similar power with PT-N and PT-NP. A data from ELEMENT study is
analyzed to examine whether a cluster consisting of seven glucose metabolites and
acetylamino acids mediate the effect of fat or carbohydrate intakes on the scores of
insulin resistance for Mexican children in the study.
Chapter III uses a copula dependence model to construct a unified mediation anal-
ysis approach to analyzing the data of mixed types, including continuous, categorical,
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count variables. We establish joint parametric distributions of exposure, mediator and
outcome featuring a lower-triangular dependence matrix reflecting DAG in the me-
diation pathway and a class of generalized linear models adjusting for confounding
factors in the respective marginal distributions. We develop estimation procedures
for the model parameters, as well as the causal effects of NDE and NIE. Simulation
studies are performed to investigate the performance under three different settings
with data of mixed types. A data from ELEMENT study with a binary mediator of
whether a child has a delayed BMI infancy peak or not is examined to understand
the association between mother’s phthalate exposure during pregnancy and offspring’s
health outcomes during peripuberty.
Chapter IV introduces a conceptual framework of generalized total, direct and in-
direct effects (GTE/GNDE/GNIE) to relax the conventional definition of NDE and
NIE, when the treatment or exposure is dichotomous. We utilize the latent exposure
variable presentation to investigate the “actions” of the dichotomous treatment in a
biomedical study. We propose two important types of models: effective dose model
and latent exposure model, in which we demonstrate that the proposed GNDE and
GNIE are more desirable to quantify and interpret compared with the conventional
definitions. The simulation studies are carried out to examine the estimation proce-
dure of the two models, and the mean bias, mean squared error and 95% coverage
rate all suggest our methods provide accurate effect estimation and valid statistical
inference. A randomized trial from the ELEMENT study is analyzed to illustrate our
method, where we examine whether the relation between mother’s calcium supple-




A Likelihood-based Test for Multi-dimensional
Mediation Effects
2.1 Introduction
Mediation analysis is undertaken pervasively in practice to understand whether or not
the effect of an exposure on an outcome has been mediated through some intermediate
variables, which are, in short, called mediators. The mediation analysis approach, first
proposed by Baron and Kenny (1986), has been extensively applied in many disci-
plines to perform pathway analyses. Utilizing the counterfactual outcome framework
in the causal inference literature (Rubin, 1978; Robins and Greenland , 1992; Pearl ,
2001), the mediation approach has been recently extended to study causal media-
tion pathways via directed acyclic graphs (DAG) formed under a certain scientific
hypothesis as shown in Figure 2.1. With a few extra assumptions of causation, such
extension allows to decompose the total causal effect into a sum of direct effect and
indirect effect in the presence of interactions and non-linearities (Pearl , 2001; Van-
derWeele and Vansteelandt , 2009). This new causal framework has received much
attention in the literature.
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Figure 2.1: A DAG involving exposure, mediators and outcome.
There are many existing methods in the literature developed to test the existence
of mediation effect (or the indirect effect) in the case of a single potential mediator,
including Sobel’s test (Sobel , 1982), bootstrap method (Bollen and Stine, 1990), joint
significant test (MacKinnon et al., 2002). Recently, with the advent of advanced
omics technologies, there has been an increasing need in testing for mediation effects
in applications with a group of multiple or even high-dimensional mediators, for which
several methods have been developed. For examples, multiple testing approaches for
genome-wide association analysis have been proposed based on simultaneous single
mediator tests with multiple comparison correction (Huang , 2019; Huang et al., 2019;
Djordjilović et al., 2019; Dai et al., 2020). In such methods, test for a causal mediation
effect has been focused on a single mediator via a univariate screening analysis of
mediators one by one, ignoring the dependence among multiple mediators. Although
multiple testing corrections have been adjusted to identify the potential mediators,
the interpretation of the causal effect is still limited to each of the selected mediators,
instead of a simultaneous inference for the group-level mediation effect. However,
in many applications when there exist multiple correlated mediators, in particular
a cohesive cluster of biologically relevant mediators, the group-level mediation effect
does not simply equal to a summation of individual mediation effects, as pointed
out by VanderWeele (2015). Therefore, the conclusion drawn from the univariate
screening test with multiple comparison correction does not necessarily produce a
valid statistical inference for the group-level mediation effect. While these univariate
screening procedures are useful to discover individually potential mediators, it is of
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critical importance to analyze a cluster of correlated multiple mediators jointly. This
analytic objective calls for a test for their group-level mediation effect.
The mediation relationships of a DAG in Figure 2.1 are extensively analyzed
by the linear normal structural equation model (SEM). When exposure-mediator
interaction terms are absent in the SEM, the group-level mediation effect is expressed
as the product, α>β, where α is the vector of coefficients for exposure-mediator
association and β is the vector of coefficients for mediator-outcome association. In
this chapter, we aim to develop a simultaneous test for the joint group-level mediation
effect under the null hypothesis of no mediation effect H0 : α
>β = 0. A key technical
challenge of performing this hypothesis test pertains to the involvement of composite
hypotheses; that is, α>β = 0 may arise from a large number of combinations in αq
and βq, q = 1, · · · , Q, where Q is the number of mediators. One example of possible
combination is α = β = 0, which is of great interest in practice. More subtle cases
may arise from cancellations among some individual products of αqβq, q = 1, . . . , Q
to satisfy α = β = 0. Two existing approaches to testing this group-level mediation
effect include: Product Test based on Normal Product distribution (PT-NP)(Huang
and Pan, 2016; Huang et al., 2018), and Product Test based on Normality (PT-N)
(Huang and Pan, 2016; Huang et al., 2018). Although these two methods have shown
satisfactory performances numerically via simulation studies, the rigorous theoretical
justification, such as the results of asymptotic distributions of such test statistics
under the null remain little explored, especially under the case of α = β = 0. To
bridge this gap, in this chapter we investigate a simultaneous likelihood ratio (LR)
test for the joint group-level mediation effect under the null hypothesis α>β = 0 in
that we establish asymptotic distributions of the proposed test statistics as well as
confirm the theoretical results by numerical analyses.
This chapter makes two methodological contributions. First, we develop a con-
strained optimization to compute the likelihood ratio test statistic under an irregular
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null parameter space using the Lagrange Multiplier. This computation is implemented
by an efficient block coordinate decent algorithm. Second, we derive the asymptotic
distributions of the proposed LR test statistic under the composite null hypothesis
H0 : α
>β = 0, and show theoretically that our LR test can properly control the
type I error. Through numerical experiments, including both simulation studies and
a data application example, we demonstrate that our LR test can not only have a
proper type I error control but also improve the power in the cases considered in the
simulation studies, in comparison to the two existing tests, PT-NP and PT-N.
The remainder of the chapter is organized as follows: Section 2.2 introduces the
linear structural equation model. Section 2.3 concerns the development of likelihood
ratio test, including the Lagrange Multiplier and the asymptotic null distributions for
the LR test statistic. Section 2.4 presents an iterative procedure for implementing
the LR test. Section 2.5 shows the numerical performance of the LR test in terms
of type I error rate and power, and its comparison to the existing methods. Section
2.6 demonstrates an application of testing for a group-level mediation effect of a
metabolite cluster on the association between dietary intakes and insulin resistance.
Section 2.7 concludes the chapter with discussions on both advantages and limitations
of the proposed LR method. Detailed technical derivations and proofs are included
in the Appendix A.
2.2 Framework
2.2.1 Structure Equation Model
Consider a data set of n observations, (Xi,Mi,j, Yi), i = 1, . . . , n, randomly sampled
from n subjects. For the i-th subject, Yi represents an outcome variable of interest,
Xi represents an exposure variable, and Mi = {Mi,j}Qj=1 represents a Q-dimensional
vector of mediators. In addition, Zi = {Zi,l}Ll=1 represents an L-dimensional vector
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of confounding variables with the first element Zi,1 ≡ 1 for the intercept. In this
chapter, we consider the case of both Q and L being fixed and Q + L + 1 < n. A
linear structural equation model (SEM) takes the following form:
Yi = Xiγ + M
>
i β + Z
>
i η + εY,i, M
>
i = Xiα
> + Z>i ζ + ε
>
M,i, (2.1)
where Mi = (Mi,1, . . . ,Mi,Q)
>, Zi = (Zi,1, . . . , Zi,L)
>, γ is a scalar, β = (β1, . . . , βQ)
>,
η = (η1, . . . , ηL)
>, α = (α1, . . . , αQ)
>, ζ = (ζl,j)L×Q, εY,i
i.i.d.∼ N(0, σ2Y ), εM,i
i.i.d.∼
MVN(0,ΣM), and ΣM is a Q×Q positive definite covariance matrix, i = 1, . . . , n.
Denote the collection of model parameters by θ = {α,β, γ,η, ζ,ΣM , σ2Y } and Θ is
a generic notation for the parameter space. In the counterfactual outcome paradigm
(Robins and Greenland , 1992; Pearl , 2001), under the fundamental assumptions of
consistency and the absence of unmeasured confounders, VanderWeele (VanderWeele
and Vansteelandt , 2014) shows that exposure variable X changes from a value x0 to
another value x1, the Natural Direct Effect (NDE) and Natural Indirect Effect (NIE)
in model (2.1) take the following forms: NDE(x0, x1) = γ(x1−x0), and NIE(x0, x1) =
α>β(x1 − x0).
2.2.2 Unconstrained Parameter Estimation
To establish a likelihood ratio test for the null hypothesis of no group-level media-
tion effect, H0 : α
>β = 0, we need to perform both unconstrianed and constrained
maximum likelihood estimations (MLE) under the null and alternative hypotheses,
respectively. SEM (2.1) may be rewritten as a matrix form:
Y = Wβ̄ + ε, M = Bᾱ + E, (2.2)
where β̄ = (β1, . . . , βQ, η1, . . . , ηL, γ)
>, Y is an n × 1 vector of the outcomes, W is
an n × (Q + L + 1) matrix of mediators, confounders and exposure variable with
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Wi = (Mi,1, . . . ,Mi,Q, Zi,1, . . . , Zi,L, Xi)
>, i = 1, . . . , n, and ε ∼ MVN(0, σ2Y In).
Similarly, M is an n×Q matrix of mediators, B is an n× (L+ 1) matrix of exposure
and confounders with Bi = (Xi, Zi,1, . . . , Zi,L), and E = (E
>
1 , . . . ,E
>
n )
> with Ei ∼
MVN(0,ΣM). Here ᾱ is an (L + 1) × Q matrix of parameters, with its first row
vector being α> in the model (2.1), and its remaining L × Q submatrix being the
parameter matrix of ζ. It follows that the two times negative log likelihood function
is given by




The standard theory of the MLE leads to the following unconstrained maximum
likelihood estimators of θ, denoted as θ̂ = { ˆ̄α, ˆ̄β, σ̂2y , Σ̂M}, where
ˆ̄α = (B>B)−1B>M, and ˆ̄β = (W>W)−1W>Y;
σ̂2y = (Y −W ˆ̄β)>(Y −W ˆ̄β)/n, and Σ̂M = (M−B ˆ̄α)>(M−B ˆ̄α)/n.
2.2.3 Constrained Parameter Estimation
Let θ̃ denote the constrained MLE under the null H0 : α
>β = 0, which will be
obtained by the method of Lagrange Multiplier. We consider a Lagrange objective
function of the following form, with tuning parameter λ,
g(ᾱ, β̄, σ2Y ,ΣM , λ) =− 2`(θ)− 2λα>β. (2.3)
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Differentiating the function g(·) with respect to the model parameters yields the
following equations of the regression coefficients,
ᾱ = (B>B)−1B>M + λ(B>B)−1β∗ΣM = ˆ̄α + λ(B
>B)−1β∗ΣM , (2.4)
β̄ = (W>W)−1W>Y + λσ2Y (W
>W)−1α∗ = ˆ̄β + λσ2Y (W
>W)−1α∗, (2.5)
and the equations of variance parameters,
σ2y = (Y −Wβ̄)>(Y −Wβ̄)/n, and ΣM = (M−Bᾱ)>(M−Bᾱ)/n, (2.6)
where β∗ is an (L+1)×Q matrix with the first row being β> and the rest of elements
are zeros, and α∗ is a (Q+L+1)×1 vector with the first Q elements being α and the
rest of elements being zero. Given that α> appears in the first row of ᾱ, we denote
the first row of ˆ̄α by a>1 , and the first row of (B
>B)−1β∗ΣM by b
>
1 . It follows that
α> = a>1 − λb>1 . Similarly, given β being in the first Q rows of vector β̄, denote the
first Q rows of vector ˆ̄β by a2, and the first Q rows of (W
>W)−1α∗ by b2. Under
the constraint α>β = 0, we obtain (a>1 + λb
>
1 )(a2 + λb2) = 0. This leads to two
possible solutions of λ given in (2.7), and we shall choose the one that yields the
higher log-likelihood,
λ̃ =
−(a>1 b2 + b>1 a2)±
√
(a>1 b2 + b
>
1 a2)
2 − 4b>1 b2a>1 a2
2b>1 b2
. (2.7)
Remark II.1. After we obtain the constrained MLE solutions (θ̃, λ̃) by the method of
the Lagrange Multiplier above, we then evaluate the Hessian matrix of the function
g(·) in (2.3). It is easy to show that in the setting of the linear SEM the Hessian matrix
is positive definite, guaranteeing the convexity of the penalized objective function g(·)
and thus the unique minimum given by the solutions (θ̃, λ̃).
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2.3 Likelihood Ratio Test for Joint Mediation Effect
2.3.1 Test Statistic
To simultaneously assess the joint mediation effect of multi-dimensional mediators,
the first analytic task is to test the null hypothesisH0 : α
>β = 0 versusH1 : α
>β 6= 0,
where the null hypothesis corresponds to the case of zero NIE under SEM (2.1).
As pointed above, since the null hypothesis allows internal cancellation, it does not
preclude the possibility of component-wise nonzero mediation effects in the sense that
αqβq 6= 0, q = 1, · · ·Q but α>β = 0. Following the classical Wilks’ theory of likelihood
ratio (LR) test, we construct a LR test statistic of the form:




`(θ)} = −2{`(θ̃)− `(θ̂)}, (2.8)
where θ̂ and θ̃ denote, respectively, the unconstrained MLE under H1 and the con-
strained MLE under H0 obtained in Sections 2.2.2 and 2.2.3.
2.3.2 Properties of the LR test
This section concerns the asymptotic distributions of the likelihood ratio statistic Tn
in (2.8) under the null hypothesis H0 : α
>β = 0. Using the large-sample properties,
we propose a new test that can properly control the type I error with theoretical
guarantees. For all lemmas and theorems presented in this section, their technical
proofs are given in the Appendix. We begin with some notations. For the ease of
exposition, we redefine θ = (α>, ζ,β>,η>, γ)>, where ζ denotes the row vector of LQ
elements vectorized from the matrix ζL×Q. Define the constraint function by h(θ) =
α>β. It is easy to see that its gradient ḣ(θ) = ∇θh(θ) = (β>,0>LQ,α>,0>L+1)>. Let

















has a closed-form, presented in Ap-




2 . To derive the asymptotic properties, we
first introduce a lemma that establishes the eigenvalue bounds of matrices H(θ) and
A(θ).
Lemma II.2. For any θ ∈ R2Q+LQ+L+1, we have the following results.
(i) The matrix H(θ) = ∇θḣ(θ) has 2Q nonzero eigenvalues equal to 1 or −1. If
nonzero eigenvalues are arranged in a descending order as of the form h1 ≥
h2 ≥ · · · ≥ h2Q, then h1 = · · · = hQ = 1, hQ+1 = · · · = h2Q = −1.
(ii) The matrix A(θ) has 2Q nonzero eigenvalues. If nonzero eigenvalues are ar-
ranged in a descending order as of the form υ1 ≥ υ2 ≥ · · · ≥ υQ > 0 > υQ+1 ≥
· · · ≥ υ2Q, then they satisfy
∑2Q
i=1 vi = 0, and υ1 = −υ2Q, υ2 = −υ2Q−1, . . . , υQ =
−υQ+1.
The above properties for the eigenvalues of A(θ) are used to establish asymptotic
null distributions of the LR test statistic. The proof of Lemma II.2 is presented in
Appendix A.2.
Lemma II.3. In the case of α = β = 0, let θ0 be the true parameters that generate
the data, and the asymptotic distributions of the constrained MLE θ̃ and λ̃ are given
by, as n→∞,
λ̃
d→ Λ0, where Λ0
d≡ −
∑Q





q (ξq + ξq+Q)
,
with ξq
i.i.d.∼ χ21, q = 1, · · · , 2Q.
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For any λ∗ ∈ R, conditional on a value λ̃ = λ∗,
√
n(θ̃ − θ0) | λ̃ = λ∗
d→ N
(
0, {I(θ0)− λ∗H(θ0)}−1I(θ0){I(θ0)− λ∗H(θ0)}−1
)
,
where υ1, . . . , υQ are Q positive eigenvalues of A(θ0).
Lemma II.3 leads to an asymptotic joint distribution of θ̃ and λ̃ due to the fact
[θ̃, λ̃] = [θ̃|λ̃][λ̃]. Thus, we obtain the asymptotic distribution of the LR test statistic
in the scenario of α = β = 0. The proof of Lemma II.3 is presented in Appendix
A.3.
Theorem II.4. Under H0 : α
>β = 0, the asymptotic distributions of the likelihood
ratio test statistic Tn are given by,
(i) when (α>,β>)> 6= 0, as n→∞, Tn
d→ χ21,
(ii) when α = β = 0, as n → ∞, Tn











i.i.d.∼ χ21, q = 1, · · · , 2Q.
In this chapter, we write Λ1 ∼ κQ distribution. The proof of Theorem II.4 involves
deriving the asymptotic distributions of the constrained MLE. Although the classical
large-sample work for the LR test, e.g. (Aitchison et al., 1958; Wolak , 1989), may be
directly applied to prove part (i) of Theorem II.4, the proof of part (ii) is non-trivial
and needs specific technical arguments and treatments on manipulating asymptotic
distribution of λ̃, similar to those given in the proof of Lemma II.3. The proof of
Theorem II.4 is presented in Appendix A.4. To implement the κQ distribution after
both matrix A(θ) and its Q eigenvalues are estimated, we invoke the Monte Carlo
simulation with a large number of draws (say 10,000) independently from 2Q χ21
distributed variables ξq, q = 1, · · · , 2Q.
It follows from Theorem II.4 that we propose a test for H0 : α
>β = 0, termed as
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LR test, given by the decision function:
φn = I[Tn > (χ
2
1,(1−α) ∨ κQ,(1−α))], (2.9)
where a∨ b = max(a, b), κQ,(1−α) is the (1−α) quantile of the null distribution given
in part (ii) of Theorem II.4, and χ21,(1−α) is the (1−α) quantile of the χ21 distribution.
When φn = 1, we reject the null H0; otherwise, accept the null H0.
Theorem II.5. The LR test in (2.9) controls the type I error; that is
sup
θ∈Θ:α>β=0
Pθ(φn = 1) ≤ α,
where 0 < α < 1 is a prefixed type I error rate.
Proof. Divide the parameter space under the H0, Θ = {(α,β) : α>β = 0} into two



























In practice, to perform the LR test φn, we first compute two p-values of p1 = 1 −
Fχ21(Tn) and p2 = 1−FκQ(Tn), where Fχ21 is the CDF of the χ
2
1 distribution, and FκQ is
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the CDF of the κQ distribution. Then we reject the null hypothesis if the max(p1, p2)
is smaller than significance level α.
To obtain the constrained MLE, we develop a block coordinate descent algorithm
given as follows. We partition θ into two sets: θ1 = { ˜̄α, ˜̄β}, and θ2 = {σ̃2Y , Σ̃M},
as well as λ. The unconstrained MLE θ̂ = { ˆ̄α, ˆ̄β, σ̂2Y , Σ̂M} are used as the initial
values to start the algorithm. This updating scheme consists of three steps: given θ1
and θ2, maximize the likelihood with respect to λ; given θ2 and λ, update θ1 until
convergence; given θ1, update θ2. The algorithm is detailed below in Algorithm 1,
where the default number of Monte Carlo simulations is set at 10,000.
Algorithm 1
• Compute the unconstrained MLE θ̂ = { ˆ̄α, ˆ̄β, σ̂2Y , Σ̂M}, and evaluate the log-
likelihood `(θ̂). At the jth-iteration, let θ
(j)





M }. Set θ
(0)
1 = { ˆ̄α, ˆ̄β} and θ
(0)
2 = {σ̂2Y , Σ̂M} as the initial values.
• For j = 0, 1, . . . , J














1 based on (2.6);
– calculate δ =‖ θ(j+1)1 − θ
(j)
1 ‖;












, and calculate the log-likelihood.




, and compute the p-value p1
under the null distribution of χ21.
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• Estimate A(θ0) based on σ̂2Y and Σ̂M , and calculate its Q positive eigenvalues
that are then used to simulate the κQ distribution, and compute its p-value p2.
• Report max(p1, p2) as the final p-value.
2.5 Simulation Studies
2.5.1 Setup
We conduct extensive simulation studies to evaluate the performance of the proposed
LR test. In particular, we compare the type I error control and power of our method
with two existing methods: PT-N and PT-NP tests proposed by Huang et al (Huang
and Pan, 2016). In addition, we consider a comparison to a recent method of High-
Dimensional Multiple Testing (HDMT) proposed by (Dai et al., 2020). HDMT was
originally developed for a univariate screening of mediators with controlled false dis-
covery rate in genome studies, representing a typical kind of testing approach widely
adopted in practice to avoid simultaneous inference. Because HDMT is not a method
established in the paradigm of the Neyman-Pearson hypothesis testing, we present
the comparison results in the Appendix A.5.
The SEM is set up as follows. The exposure variable X is simulated from N(0, 1),
and two confounding variables Z1 and Z2 are generated from BV N(0, I2). Given X
and (Z1, Z2), throughout the entire simulation experiments in this section, Q medi-
ators M and outcome Y are generated according to the SEM (2.1), with Q = 30,
γ = −2, η = (2,−3, 2)>, σ2Y = 1, and vec(ζ) consists of 18 repeated sequences of
(−2, 3,−3, 1, 1). The sample size n varies over 200, 500, and 1000. For each sample
size, we run 10,000 replicates.
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2.5.2 Type I Error
We consider the following four scenarios of the null hypotheses: (i) sparse pathways
with no cancellation; (ii) sparse pathways with cancellation; (iii) non-sparse pathways
with cancellation; and (iv) fully sparse pathways α = β = 0. Here sparsity refers to
the number of zero parameters in α and/or β. The detailed specifications of α and
β can be found in Table 2.1. We report in Table 2.2 the estimated empirical type I
error rate as the proportion of rejections from the 10,000 replicates. For the four null
cases (i)-(iv), our LR test as well as two existing PT-N test and PT-NP test showed a
proper control of the type I error. In the cases (i)-(iii), these three methods show their
empirical type I error rates close to the nominal level 0.05, as desired. In the case
(iv), they are all conservative, but our LR test appears to be the least conservative
among the three.
2.5.3 Power Comparison
We evaluate and compare power under the same basic model specifications above, in
which α and β are specified in four sets of alternative scenarios different from the null
hypothesis; see the detail in Table 2.1. The design for the four alternative hypotheses
corresponds the following scenarios of pathways: (v) both α and β are sparse; (vi) α
is sparse and β is not sparse; (vii) α is not sparse and β is sparse; and (viii) both α
and β are not sparse. Regardless of specific settings, the overall absolute group-level
effect is fixed at 0.16, i.e. |α>β| = 0.16. Table 2.2 reports the estimated empirical
power by the proportion of rejections to the null from 10,000 replicates.
We calculate the percent of power increase of LR over a competing method by
power of LR
power of competitor
− 1. For all cases, our LR method demonstrates clearly higher
power than existing PT-N and PT-NP tests, especially when the sample sizes are small
or moderate, say 500 or less. It is also noteworthy that even though the mediation
effect size is fixed constantly at 0.16 across four cases, the power varies according to
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Table 2.1: Designed specifications for α and β for null and alternative hypotheses.
Mediator
Null Hypothesis (α>β = 0) Alternative Hypothesis (|α>β| = 0.16)
i ii iii iv v vi vii viii
α β α β α β α β α β α β α β α β
1 0.2 0 0.2 0 0.2 -0.2 0 0 0.4 0.4 0 0.3 0.3 0 0.4 0.4
2 0.5 0 0.2 0.5 0.3 0.1 0 0 0 -0.8 0 0.3 0.3 0 0.2 -0.2
3 0 0.2 0.5 -0.2 0.1 0.1 0 0 0 0 0 0.3 0.3 0 0.3 0.1
4 0 0.5 0.2 0.5 0.2 -0.2 0 0 0 0 0 0.3 0.3 0 0.1 0.1
5 0 0 -0.2 0.5 0.3 0.1 0 0 0 0 0 0.3 0.3 0 0.2 -0.2
6 0 0 0 0 0.1 0.1 0 0 0 0 0.2 -0.8 -0.8 0.2 0.3 0.1
7 0 0 0 0 0.2 -0.2 0 0 0 0 0 0 0 0 0.1 0.1
8 0 0 0 0 0.3 0.1 0 0 0 0 0 0 0 0 0.2 -0.2
9 0 0 0 0 0.1 0.1 0 0 0 0 0 0 0 0 0.3 0.1
10 0 0 0 0 0.2 -0.2 0 0 0 0 0 0 0 0 0.1 0.1
11 0 0 0 0 0.3 0.1 0 0 0 0 0 0 0 0 0.2 -0.2
12 0 0 0 0 0.1 0.1 0 0 0 0 0 0 0 0 0.3 0.1
13 0 0 0 0 0.2 -0.2 0 0 0 0 0 0 0 0 0.1 0.1
14 0 0 0 0 0.3 0.1 0 0 0 0 0 0 0 0 0.2 -0.2
15 0 0 0 0 0.1 0.1 0 0 0 0 0 0 0 0 0.3 0.1
16 0 0 0 0 0.2 -0.2 0 0 0 0 0 0 0 0 0.1 0.1
17 0 0 0 0 0.3 0.1 0 0 0 0 0 0 0 0 0.2 -0.2
18 0 0 0 0 0.1 0.1 0 0 0 0 0 0 0 0 0.3 0.1
19 0 0 0 0 0.2 -0.2 0 0 0 0 0 0 0 0 0.1 0.1
20 0 0 0 0 0.3 0.1 0 0 0 0 0 0 0 0 0.2 -0.2
21 0 0 0 0 0.1 0.1 0 0 0 0 0 0 0 0 0.3 0.1
22 0 0 0 0 0.2 -0.2 0 0 0 0 0 0 0 0 0.1 0.1
23 0 0 0 0 0.3 0.1 0 0 0 0 0 0 0 0 0.2 -0.2
24 0 0 0 0 0.1 0.1 0 0 0 0 0 0 0 0 0.3 0.1
25 0 0 0 0 0.2 -0.2 0 0 0 0 0 0 0 0 0.1 0.1
26 0 0 0 0 0.3 0.1 0 0 0 0 0 0 0 0 0.2 -0.2
27 0 0 0 0 0.1 0.1 0 0 0 0 0 0 0 0 0.3 0.1
28 0 0 0 0 0.2 -0.2 0 0 0 0 0 0 0 0 0.1 0.1
29 0 0 0 0 0.3 0.1 0 0 0 0 0 0 0 0 0.2 -0.3
30 0 0 0 0 0.1 0.1 0 0 0 0 0 0 0 0 0.3 0.2
Table 2.2: Empirical type I error under four null hypotheses, and power under four
alternative hypotheses with 10,000 replicates. The sample size varies from
200, 500, and 1,000. The exchangeable correlation of mediators is set with
correlation 0.5. Power increase (%) =
power of LR test
power of competing test
− 1.
n Method
Null Hypothesis Alternative Hypothesis Percent of power increase
i ii iii iv v vi vii viii v vi vii viii
LR 0.050 0.052 0.051 0.009 0.591 0.562 0.312 0.507 - - - -
200 PT-N 0.038 0.042 0.037 0.005 0.550 0.536 0.255 0.458 7.46% 4.78% 22.51% 10.72%
PT-NP 0.032 0.038 0.028 0.001 0.507 0.497 0.242 0.426 16.55% 13.07% 28.72% 19.20%
LR 0.046 0.049 0.045 0.007 0.970 0.954 0.648 0.928 - - - -
500 PT-N 0.041 0.045 0.039 0.005 0.967 0.953 0.624 0.922 0.30% 0.12% 3.78% 0.66%
PT-NP 0.038 0.044 0.035 0.001 0.962 0.947 0.620 0.916 0.78% 0.75% 4.5% 1.36%
LR 0.051 0.049 0.046 0.006 1.000 1.000 0.917 0.999 - - - -
1000 PT-N 0.048 0.048 0.043 0.004 1.000 1.000 0.911 0.999 0.00% 0.00% 0.67% 0.01%
PT-NP 0.046 0.049 0.041 0.000 1.000 1.000 0.910 0.998 0.00% 0.00% 0.71% 0.05%
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Figure 2.2: Power curves of three tests (LR, PT-N, and PT-NP) under the simulation
case (vii) with sample size n = 200 and δ varing from 0 to 0.50 by an
increment unit of 0.02.
the underlying parameter configurations and sparsity. Among these four cases, case
(vii) appears to be the most challenging scenario, where β is most sparse with a small
magnitude of nonzero element in β. To further examine the performance of these
tests, in case (vii) with the sample size 200, we set the single nonzero β coefficient at
0.2 + δ with δ varying from 0 to 0.50 by an increment of 0.02 to illustrate the power
increase pattern. Figure 2.2 shows all three power curves increase to 1 when the
size δ in the alternative hypothesis becomes further distant from the null hypothesis.
Our LR test is more powerful than the other competing tests. Empirically, these
three tests are all shown to be consistent as their power rises to 1 when the deviation
from the null tends to infinity. Taking all other settings in the simulation study
into account, overall, we conclude that our LR test shows higher power in comparison




We apply the proposed LR test to analyze a real world data example from a pediatric
cohort study consisting of 203 children, with 96 boys and 107 girls, age 8.1 to 14.4
years old. We consider two exposure variables X of macronutrient intakes calculated
as the energy adjusted carbohydrate and fat. They are termed as carbohydrate intake
and fat intake, respectively, obtained from the food frequency questionnaires (Willett
et al., 1997). The outcome variable Y is a HOMA-CP score defined by Li et al.
(2004), which measures insulin resistance using the C-peptide biomarker produced by
pancreas. A higher HOMA-CP score means more insulin resistant, leading potentially
to a higher risk of developing diabetes in adulthood years.
In this analysis, we focus on studying a cluster of seven metabolites of glu-
cose metabolites and acetylamino acids annotated by our collaborator Dr. Labarre
(LaBarre et al., 2020) at the University of Michigan Research Core of Metabolomics.
One metabolite in this cluster is N-acetylglycine, which have been found in the lit-
erature to be positively associated with dietary fiber intake (Lustgarten et al., 2014)
and negatively associated with metabolic risk score (Perng et al., 2017). The goal of
central interest is to test if a cohesive cluster containing N-acetylglycine is involved
as a group in a mediation pathway from dietary intakes to HOMA-CP score. This
scientific question pertains to a hypothesis that food intakes may change metabo-
lites and then further alter function of pancreas, so to elevate the risk of developing
diabetes during later life time.
With the consultation with our collaborator, we choose a set of confounding vari-
ables, including age, gender, and puberty onset. We begin the data analysis to assess
the total effect by fitting a linear model with outcome HOMA-CP on exposures to
carbohydrate intake and fat intake, respectively, as well as the confounders. The
estimated total effects are -0.015 with a p-value of 0.174 for fat intake and 0.004 with
a p-value of 0.252 for carbohydrate intake. In the following analysis, we focus on
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the pathway mediation analysis from exposures to outcome.We then calculate the
p-values for the null hypothesis H0 : α
Tβ = 0 with Q = 7 using three methods of
LR, PT-N and PT-NP. We perform the testing for the group-level mediation effect
with exposure of fat intake, and obtain p-values equal to 0.01 (LR), 0.02 (PT-N), and
0.02 (PT-NP). Likewise, with exposure of carbohydrate intake, we obtain p-values
0.03 (LR), 0.04 (PT-N) and 0.04 (PT-N). All three methods reach an agreement that
with 95% confidence this cluster of seven metabolites exhibits a significant group-level
mediation effect on the associations between dietary intakes and HOMA-CP score.
With no surprise, the LR test appears to have smaller p-values in both cases, being
consistent with the findings in the simulation studies.
Taking a closer look at individually each of the seven metabolites in the cluster, we
report in Table 2.3 estimates of the individual model parameters in α, β and α ◦ β,
where ◦ is the element-wise product. The group-level mediation effects of fat and
carbohydrate intakes through the seven metabolites are -0.012 and 0.003, respectively.
For fat intakes, the negative mediation effect indicates that more fat intakes help
reduce the insulin resistance through metabolites, where N-acetyglicine contributes
most to the reduction of the insulin resistance score. In contrast, carbohydrate intakes
increase the insulin resistance through metabolites, where again N-acetyglicine
contributes most.
Table 2.3: Estimated coefficients for a cluster of seven metabolites.
Metabolite
Fat Carbohydrate
α β α ◦ β α β α ◦ β
L-histidine -0.0019 0.334 -0.0006 0.0008 0.334 0.0003
N-acetyl-D-glucosamine -0.0046 0.197 -0.0009 0.0009 0.200 0.0002
N-acetyl-DL-serine 0.0055 0.206 0.0011 -0.0017 0.204 -0.0004
3,4-hydroxyphenyl-lactate 0.0014 0.114 0.0002 -0.0006 0.114 -0.0001
2-deoxy-D-glucose 0.0041 -0.356 -0.0015 -0.0013 -0.356 0.0005
N-acetylglycine 0.0101 -0.840 -0.0085 -0.0030 -0.842 0.0025
D-lyxose -0.0050 0.291 -0.0015 0.0016 0.294 0.0005
25
2.7 Concluding Remarks
This chapter studied a likelihood ratio approach to testing a group-level mediation
effect with multiple mediators. We were able to overcome a key technical challenge
arising from the constrained maximum likelihood estimation under irregular param-
eter spaces. In particular, the Lagrange Multiplier method was developed to carry
out the constrained optimization via an efficient block coordinate decent algorithm,
which was required to implement our LR test statistic. We established the asymptotic
distributions of the proposed LR test statistic, in which a theoretical guarantee was
given for a proper control of the type I error. Through both simulation studies and a
data application, our LR method has showed less conservative and higher power than
two existing methods, PT-N test and PT-NP test, especially when the sample size is
moderate or small.
To apply our LR approach to testing for a cluster of high-dimensional potential
mediators, one needs to first divide them into subgroups according to prior scientific
knowledge or certain clustering techniques, and then carry out the test for a group-
level mediation effect, each for one subgroup of mediator. A future work of interest
would be to extend the current framework to the case of high-dimensional mediators
with no need of dividing them into subgroups.
All test methods, including our LR test, have appeared to be conservative for the
null case of α = β = 0. This is an open problem in the theory of statistical inference
for mediation effect, even in the setting of one single mediator. Some better solutions
to overcome such conservatism are worth future exploration. In addition, extending
the normal linear structural equation model to a more general model such as the
family of generalized linear models and Cox proportional hazards model is appealing
to deal with a broader range of data types and practical problems. Developing LR
tests for group-level mediation effects beyond the linear structural equation model is
an important research direction of great interest.
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CHAPTER III
Generalized Structural Equation Models for
Mediation Analysis with Data of Mixed Types
3.1 Introduction
In many biomedical studies, mediation analysis has received considerable attention as
the choice of method to investigate a hypothesized mechanistic causal pathway that
involves two or more potential causal factors. The mechanistic pathway of interest is
typically organized as a form of direct acyclic graph (DAG) shown in Figure 3.1 (a),
which enables us to understand how the effect of exposure X on outcome Y may be
mediated through some intermediate variable M , called mediator. In addition to the
direct causal path from exposure X to outcome Y denoted by (X → Y ), there exists
another causal path where exposure X causes mediator M denoted by (X →M), and
then M affects outcome Y denoted by (M → Y ). As a result, the mediation pathway
has a route X → M → Y . These causal effects may be parameterized by α, β and
γ in the DAG shown in Figure 3.1(a), corresponding to, respectively, the exposure-
mediator, mediator-outcome and exposure-outcome relationships, and these directed
edges or associations may be adjusted for a set of confounders W shown in Figure
3.1(b). The primary objective of a mediation analysis is twofold: (i) to evaluate the
effect of exposure on outcome when the mediator is held constant, X → Y , termed
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Figure 3.1: A DAG involving exposure, mediator and outcome: (a) randomization
without confounders; (b) non-experimental study
as direct effect (DE); and (ii) to evaluate the effect of exposure on outcome through
the mediator, X →M → Y , termed as mediation effect or indirect effect (IE).
Two types of modeling approaches are widely utilized in mediation analyses. The
first type refers to the classical approach originally developed by Baron and Kenny
(1986) through a system of linear regression models, the so-called structural equation
modeling (SEM), which has been regarded as a standard methodology routinely used
in practice. The second type emerges recently as a causal inference approach, which
is formulated within the potential or counterfactual outcome framework (Robins and
Greenland , 1992; Pearl , 2001). The latter has attracted considerable attention in
the recent literature because of its role in making causal inference with two poten-
tial causal factors, an important extension from the causal inference literature with
a signal causal factor. In the counterfactual framework, both DE and IE are later
generalized to the so-called natural direct effect (NDE) and natural indirect effect
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(NIE), in which some essential assumptions required to identify these natural causal
effects have been extensively discussed in the literature (Imai et al., 2010b; Coffman
and Zhong , 2012; Preacher , 2015). Unfortunately, these identifiability assumptions
cannot be checked in practical studies, imposing a great challenge in the use of the
second type of mediation analysis approach. For example, “sequential ignorability”
(Imai et al., 2010b) is one of such assumptions, which requires the absence of unmea-
sured confounding in the DAG. Although it is hard to justify this condition, some
sensitivity analyses may be performed to assess reproducibility of results by carefully
designed variations of confounding scenarios.
A noticeable analytic limitation in contrast to the popularity of the mediation
analysis methodology lies in the fact that mediator and/or outcome are often as-
sumed to be continuous and normally distributed in the current literature. As seen
in our motivating example in Section 3.2, mediator and/or outcome can be continu-
ous, categorical or count variable. There are some scattered works concerning ad hoc
cases, such as categorical mediator and/or outcome, or continuous but nonnormal
mediator and/or outcome (VanderWeele and Vansteelandt , 2014, 2010; Albert and
Nelson, 2011; Huang et al., 2004; Tingley et al., 2014). Usually, stronger model as-
sumptions are imposed when data are of mixed types. Moreover, as becoming evident
throughout this chapter, causal interpretations appear to be model-specific. When
the joint normality is absent, there lacks of a unified framework of mediation analysis
to handle data of mixed types, including modeling approach, statistical estimation
and inference, software and interpretations. This motivates us to develop a flexible
class of statistical models and analytics suitable for mediation analysis with data of
mixed types. We propose to invoke copula dependence models to accommodate a
broad range of data types.
In a similar spirit to the copula regression with data of mixed types developed
by Song et al. (2009), we propose a class of generalized structural equation mod-
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els (GSEMs) through Gaussian copulas to perform mediation analyses in that data
may be of mixed types. This class of GSEMs provides three new methodological
advantages: first, we develop a unified approach to analyzing exposure, mediator
and outcome that may have different types, either categorical, discrete or continu-
ous. Adopting the tool of copula dependence models, GSEMs gives rise to a general
framework along with the generalized linear models (GLMs). Second, we jointly
model exposure, mediator and outcome, and derive the joint likelihood function un-
der different data scenarios, which is more flexible and rigorous than the approaches
based only on the mean model for E(Y | M,X,W). Third, utilizing the hierarchical
model specification, we develop a two-stage estimation procedure, where we handle
the confounding factors in the first stage, allowing us to properly adjust for complex
confounding scenarios without complicating the estimation of directed associations
or causal effects in the second stage.
The remainder of the chapter is organized as follows: Section 3.2 introduces the
motivating ELEMENT study. Section 3.3 describes GSEMs specified by a hierar-
chical copula mediation model approaches. Section 3.4 discusses the estimations of
parameter and causal effects under eight scenarios of mixed data types, where ex-
posure, mediator and outcome are continuous or discrete. Section 3.5 presents three
examples to illustrate the proposed GSEM methodology. Section 3.6 reports exten-
sive simulations to assess the performance of the GSEM methodology under three
settings. Section 3.7 demonstrates an application of mediation analysis in the ELE-
MENT study. Section 3.8 concludes the chapter with discussions on the advantages
and limitations of the proposed methodology. Detailed technical derivations are in-
cluded in Appendix B.
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3.2 ELEMENT Study
The data motivating our new methodology development comes from the “Early Life
Exposures in Mexico to ENvironmental Toxicants” (ELEMENT) cohort study. ELE-
MENT recruited three birth cohorts of 1,643 mother-child pairs during pregnancy or
delivery from maternity hospitals in Mexico city between 1993 and 2004 (Hu et al.,
2006; Perng et al., 2019). The main objective is to study how environmental tox-
icants, such as phthalates, affect maternal and child health outcomes. Phthalates
are a group of chemicals mostly used in plastics, and high levels of these chemicals
during pregnancy have shown substantial adverse health effects on both mother and
child (Qian et al., 2020). Previous study has demonstrated third trimester maternal
phthalate exposures of MEHHP, MEOHP and MIBP are linked to delayed infancy
Body Mass Index (BMI) peak (Zhou et al., 2021). Another literature has found that
later age at infancy BMI peak has been associated with higher cardiometabolic risk
biomarkers measured from children during peripuberty (Perng et al., 2018). It is of
great interest to understand potential causal mediation pathways among prenatal ph-
thalate exposure, child’ growth in early life, and child’s cardiometabolic risk later in
life. Thus, we hypothesize that the association between phthalate exposures during
mothers’ second and third trimesters and health outcomes of children in peripuberty
may be mediated by the timing and tempo of children reaching their infancy BMI
peak (labeled as on time or delayed).
The motivating data consists of 205 mother-child pairs, where prenatal expo-
sures were measured between 1997 and 2005, while the child’s cardiometabolic risk
biomarkers were measured between 2008 to 2012. There are 97 boys and 108 girls.
The mean ages of mothers at birth, and children at measurement during peripuberty
are 27.7 yrs and 10.1 yrs, respectively.
The potential mediator, the timing of infancy BMI peak is given by estimated
age (in month) when a child reaches his/her BMI peak between birth to 36 months.
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Infancy BMI peak is an important milestone for the early-life growth, as well as an
indicator for later obesity development for children (Jensen et al., 2015; Börnhorst
et al., 2017). The estimated age is calculated from child’s growth trajectory obtained
by fitting eight serial anthropometry measurements in the Newton’s Growth Models
(Baek et al., 2019). If the BMI peak was not reached before 36 months, it was
categorized as delayed (M = 1), otherwise as on time (M = 0). There are 27.8% of
children who were delayed in reaching their infancy BMI peaks.
The exposure variables include six urinary concentrations of phthalate metabo-
lites (MEHHP, MEOHP, and MIBP) measured at the second trimester among 177
women and third trimester among 202 women. These three phthalate exposures at
the third trimester were previously found to be positively associated with delayed in-
fancy BMI peak (Zhou et al., 2021). The outcome variables are three cardiometabolic
biomarkers measured from children during peripuberty, including fasting glucose z-
score, C-peptide z-score and a metabolic syndrome risk z-score (MetS z-score). Fast-
ing glucose is a screening tool for diabetes. C-peptide is a substance released from
pancreas when producing insulin. MetS z-score was calculated as the average of
five z-scores for waist circumference, fasting glucose, C-peptide, ratio of triglycerides
and High-density lipoprotein cholesterol, and average of systolic and diastolic blood
pressures (Perng et al., 2018).
Confounders W1 including mom’s age at birth, education, and marital status are
factors that occur prior to exposures, and they would influence exposures to toxicants,
mediator and outcomes. Confounders W2 including breastfeeding duration, parity,
child’s gender, gestational age, and birth weight are factors that occur after exposures
to toxicants, and would influence mediator and outcomes. Note that W2 are assumed
to be not affected by exposures, a key assumption for identification of natural causal
effects. Figure 3.2 describes hypothetical associations among exposures to phthalates
(X), BMI infancy peak M , child’s health outcomes Y as well as confounders W1,W2.
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Figure 3.2: Association between phthalate exposures and health outcomes mediated
by whether child’s timing of reaching BMI peak is delayed or not.
3.3 Generalized Structural Equation Models
3.3.1 Framework
We begin with a discussion on our general modeling approach to constructing a joint
distribution for three variables (X,M, Y ) of mixed types under the graphic topology
of acyclic direct graph (DAG) shown in Figure 3.1(a). Such joint distribution is
specified by a hierarchical modeling approach, which enables us to define a class
of generalized structural equations models (GSEMs) to address practical needs in
mediation analyses with data of mixed types. The key feature in the classical linear
normal SEM is that the covariance matrix of (X,M, Y ), denoted by, Γ, takes a special
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form arising from a DAG, given as follow:
Γ = (I−Θ)−1 Σ (I−Θ)−> , (3.1)




y) is a diagonal matrix of marginal
variances, each for one variable. More specifically, similar to the classical SEM to








To incorporate the specification (3.1) in the formulation of a valid joint probability
distribution for X, M , Y of mixed data types, we need to generalize the classical
linear normal SEM to cases of nonlinear non-normal SEM, referred to as generalized
structural equation models (GSEMs) in this chapter. We propose to construct a
GSEM with the following modeling elements:
(i) The constructed joint distribution has to be so flexible that it can allow different
types of marginal distributions because variables X,M, Y may be continuous,
discrete or categorical in practical studies.
(ii) The proposed joint distribution accommodates an explicit form of the covariance
or correlation matrix of a given form similar to that in (3.1) and (3.2). Such
matrix form is deemed critical importance to model the topology of a DAG and
to interpret parameters pertinent to mediation pathways.
(iii) Confounding factors do not enter the hierarchy of covariance matrix as shown
in (3.1) and (3.2); rather, they are adjusted at the hierarchy of marginal dis-
tributions of individual variables, respectively. This consideration essentially
suggests a hierarchical model specification where the marginal parameters and
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dependence parameters are handled by different hierarchies of GSEMs.
(iv) The classical linear normal SEM is a special case of the proposed generalization.
These modeling characteristics above, as shown in the chapter, can be incorporated
simultaneously in the proposed joint distribution by the copula modeling approach;
see for example, Song et al. (2009) where a class of vector GLMs (VGLMs) is con-
structed with data of mixed of types. Here, we consider a more complicated scenario
than VGLMs in which the dependence matrix takes a restricted form (3.1) and con-
founding factors are only allowed to enter the model in the hierarchies of marginal
distributions. The Fréchet’s theory of constructing multivariate distribution by bi-
variate distributions is the theoretical basis to ensure the validity of our proposed
hierarchical models (Joe, 2014).
Copula models provide a natural hierarchical modeling framework to satisfy the
above modeling requirements. According to Sklar’s Theorem (Sklar , 1959), when
(X,M, Y ) are continuous random variables, their joint distribution can be expressed
as
F (x,m, y) = C{Fx(x; ·), Fm(m; ·), Fy(y; ·); Γ}. (3.3)
where Fj(·) and fj(·) are the cumulative distribution function and density function,
respectively, and C(·) is a suitable copula function that is independent of marginal
parameters. This expression provides a hierarchical modeling framework, as desired.
To incorporate the covariance structure given in (3.1) in the copula function, in this
chapter we choose the Gaussian copula (Song , 2000) given as follows:
C(u1, u2, u3) = Φ3{Φ−1(u1),Φ−1(u2),Φ−1(u3); Γ}, (3.4)
where Φ3(·; Γ) is a trivariate Gaussian distribution function with mean zero and cor-
relation matrix Γ, and Φ(·) is the standard univariate Gaussian distribution function
and Φ−1(·) is the corresponding quantile function. Since all marginal parameters, in-
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clude the variance parameters, are exclusively included in the marginal distributions,
the dependence matrix Γ does not contain any marginal variance parameters but only
correlation parameters. All parameters in Γ represent rank-based correlations, more
general dependencies than Pearson correlations.
Following Song et al. (2009), we propose to extend the copula model (3.3) with
a Gaussian copula by allowing distributions of both continuous and discrete random
variables and Γ satisfying DAG model (3.1). In this way, the resulting joint distri-
bution can be used to handle variables of mixed types, and to perform mediation
analyses. We will focus on our discussion in two important settings: GSEMs with no
confounders in Section 3.3.2 under double randomized trials, and GSEMs in observa-
tional studies in Section 3.3.3 in the presence of confounding factors.
3.3.2 GSEMs under No Confounders
We first consider the most favorable scenario: there are no confounders involved in the
relationships among exposure, mediator and outcome. One such case can be achieved
by randomization of both X and M (Preacher , 2015). This is the simplest setting
in the mediation analysis for us to introduce the copula model. We consider three
generalized linear models (GLM) that the marginal distributions of X, M and Y are
elements of exponential dispersion family distribution (ED) models (Jørgensen, 1987)
denoted by
X ∼ ED(µx, φx),M ∼ ED(µm, φm), Y ∼ ED(µy, φy), (3.5)
where (µx, µm, µy),and (φx, φm, φy) are the respective mean parameters and dispersion
parameters. Note that these mean parameters are not modeled by covariates. Denote
by Fx(x; ·), Fm(m; ·) and Fy(y; ·) the cumulative distribution functions of X, M and
Y , respectively. As a result, we are able to obtain a joint distribution of (X,M, Y )
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via a copula function C(u1, u2, u3; Γ) in (3.3). It can be shown that (3.3) under
assumptions (3.1), (3.2) and (3.4) is equivalent to the Gaussian copula model (3.6)
based on latent variable representation. Let Zx, Zm and Zy be three respective latent
variable. Then (3.1)-(3.4) may be equivalently represented by,
Zx ∼ N(0, 1),
Zm | Zx ∼ N(αZx, 1),
Zy | Zx, Zm ∼ N(γZx + βZm, 1). (3.6)
We can link observed variables with the latent variables via marginal quantile
transformations: X = F−1x {Φ(Zx)}, M = F−1m {Φ(Z∗m)} and Y = F−1y {Φ(Z∗y )}, where
Z∗m = Zm/τm, Z
∗
y = Zy/τy, τm =
√
α2 + 1, and τy =
√
(γ + αβ)2 + β2 + 1. The
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If X is a continuous variable, X = F−1x {Φ(Zx)} becomes Zx = Φ−1(Fx(X)),
namely the quantile of the standard normal distribution. If X is a discrete variable
with non-zero point probability mass at 0, 1, 2, · · · , then X =
∑∞
x=0 xI(Fx(x − 1) ≤
Φ(Zx) < Fx(x)). This implies that the event {X = x} is equivalently to the event
{Φ−1(Fx(x − 1)) ≤ Zx < Φ−1(Fx(x))}. For simplicity, denote the lower and upper
bounds of the normal quantiles as Φ−1(Fx(x − 1)) = lx, and Φ−1(Fx(x)) = ux in
the rest of this chapter. Similar results hold for latent variable Z∗m with respect to




respect to outcome Y , with lower and upper quantile bounds denoted by ly and uy.
X, M and Y may be either continuous or discrete, we have a total of eight data
type scenarios. For example, “CCC”, “CDC” and “CCD” represent X, M , and Y
are continuous; X and Y are continuous, M is discrete; X and M are continuous,
Y is discrete, respectively. Table 3.1 presents the expressions of the corresponding
likelihood functions, each for one scenario. The detailed derivation of π(X,M, Y ) is
summarized in Appendix B.2.
Table 3.1: Joint distribution of X, M and Y , π(X,M, Y ) and expectation of potential
outcome E{Y (Xa,M(Xb))} under eight scenarios, where X, M and Y are
either continuous or discrete.
X M Y π(X,M, Y )
C C C π(Zx, Z∗m, Z
∗
y )
C C D π(Zx, Z∗m)P
(
Z∗y ∈ (ly , uy)|Zx, Z∗m
)
C D C π(Zx, Z∗y )P
(
Z∗m ∈ (lm, um)|Zx, Z∗y
)
C D D π(Zx)P
(
Z∗m ∈ (lm, um), Z∗y ∈ (ly , uy)|Zx
)




Zx ∈ (lx, ux)|Z∗m, Z∗y
)
D C D π(Z∗m)P
(
Zx ∈ (lx, ux), Z∗y ∈ (ly , uy)|Z∗m
)
D D C π(Z∗y )P
(
Zx ∈ (lx, ux), Z∗m ∈ (lm, um)|Z∗y
)
D D D P
(
Zx ∈ (lx, ux), Z∗m ∈ (lm, um), Z∗y ∈ (ly , uy)
)
















y=1 yP (ly ≤ Z∗y < uy |Zx = zxa , Z∗m = z∗m)π(Z∗m|Zx = zxb )dZ∗m
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∑∞




















































y=0 yP (ly ≤ Z∗y < uy |lxa ≤ Zx < uxa , lm ≤ Z∗m < um)P (lm ≤ Z∗m < um|lxb ≤ Zx < uxb )
C: Continuous variable. D: Discrete variable.
Now let us study causal effects under the above model (3.1)-(3.4). To analyze
natural direct effect (NDE) and natural indirect effect (NIE), we adopt the poten-
tial outcome framework from the causal inference literature (Splawa-Neyman et al.,
1990; Rosenbaum and Rubin, 1983; Pearl , 2001; Robins and Greenland , 1992). Fol-
lowing existing the counterfactual notions (VanderWeele and Vansteelandt , 2009),
let Y (x,m) denote the counterfactual outcome that would have been observed for a
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subject had the exposure X been set to value x and mediator M to the value m;
let M(x) be the counterfactual value of mediator had the exposure X been set to x.
Then E{Y (xa,M(xb))} is the expected outcome of Y had the exposure been set to
xa and mediator been set to M(xb), namely
E{Y (xa,M(xb))} = EM [EY {Y |M,X = xa}|X = xb].
Both NDE and NIE for a change of X from x0 to x1 are given by, respectively
NDE(x0, x1) = E{Y (x1,M(x0))} − E{Y (x0,M(x0))}, (3.8)
NIE(x0, x1) = E{Y (x1,M(x1))} − E{Y (x1,M(x0))}.
These are primarily determined by the hierarchies of causal effects dependencies
among X, M and Y .
3.3.3 GSEMs in Observational Studies
Next we consider the setting of a non-experimental design, such as an observa-
tional studies, where confounding factors are used to adjust for selection bias. Let
W = (W>1 ,W
>
2 )
> denote a matrix of all the confounding factors available in the
dataset, where W1 = (W1,1, . . . ,W1,p1)
> influences X, and W influences M and Y .
For simplicity, the first element of W is set to 1 for the intercept. For the identifi-
cation of NDE and NIE, we impose the same assumptions discussed in the literature
(VanderWeele and Vansteelandt , 2009; VanderWeele, 2015): (i) there are no unmea-
sured confounders of the associations between X and M , between M and Y , and
between X and Y , respectively; (ii) no confounders of M and Y that are influenced
by X. Then the hierarchy of marginal models, adjusting for confounders, is specified
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by a set of three conditional density functions of X, M and Y given W1 and W:
X |W1 ∼ ED(µx, φx), gx(µx) = W1βx,
M |W ∼ ED(µm, φm), gm(µm) = Wβm,
Y |W ∼ ED(µy, φy), gy(µy) = Wβy, (3.9)
where βx,βm and βy are vectors of regression coefficients; and φ(x), φ(m) and φ(y)
are the dispersion parameters. In a similar way, we can establish the latent variable
representation in the mediation analysis, as done for model (3.6).
When confounders are present, both NDE and NIE are given similarly as (3.8),
with the inclusion of confounders in the marginal mean parameters, precisely, we
would consider conditional NDE and NIE given W = w as follows,
NDE(x0, x1; w) = E{Y (x1,M(x0)) |W = w} − E{Y (x0,M(x0)) |W = w},
NIE(x0, x1; w) = E{Y (x1,M(x1)) |W = w} − E{Y (x1,M(x0)) |W = w}. (3.10)
This is natural as DAG is specified in the hierarchy adjusted by confounders in the
marginal distributions. Compared with the conventional structural equation modeling
approach to mediation analysis, one distinction for the GSEM methodology is that
instead of conditioning on the exposure variable X, we propose to hierarchically model
the marginal distribution of X and DAG for causal effects, where covariates W1 are
used to adjust nodes not edges of DAG in Figure 3.1(b). One advantage of modeling
X: scientifically, it is often the case that covariates W1 affect exposure X, M and
Y , so the change of X may be due to the change of W1, however the conventional
structural equation models ignore the dependence between X and W1, when they
define the causal effects based on the change of X. Our proposed GSEMs models the
change of X conditional on W to define the causal effects.
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3.4 Parameter and Effect Estimations
3.4.1 Estimation of Model Parameters
We consider a general GSEM under non-experimental design given in Section 3.3.3,
includes the setting with no confounders in Section 3.3.2 as a special case. Sup-
pose we have a dataset of n observations, (Xi,Mi, Yi), i = 1, · · · , n. Although the
exact likelihood fuction is available , optimization is computationally challenged. For
consideration of practical usefulness, we adopt a computationally efficient method.
Following the methodology of inference function for margins (IFM) (Xu, 1996; Joe,
2005; Shih and Louis , 1995; Ferreira and Louzada, 2014; Ko and Hjort , 2019), we
develop a two-stage profile likelihood estimation procedure. The first stage involves
fitting GLMs respectively on three univariate margins, Xi, Mi and Yi to obtain the
regression coefficients βx, βm and βy and dispersion parameters; and the second stage
involves searching the dependence parameters α, β and γ given the estimates from
the first stage.
Step I fits Xi marginally on covariates W1 via a GLM and obtain estimated
regression coefficients β̂x, as well the subject-specific estimates µ̂xi and φ̂xi , where
dispersion parameter φ̂xi may be assumed the same across the subjects, i.e., φ̂x. Then
for each subject i, we calculate Zxi from µ̂xi and φ̂x. Zxi could be either a unique
value if X is continuous or a range if X is discrete with lower and upper bounds.




II plugs in Zxi , Z
∗
mi
and Z∗yi to one log-likelihood function
∑n
i=1 log π(Xi,Mi, Yi) in
Table 3.1, which is a function of three parameters α, β and γ. We call “optim”, the R
function to search for estimates α̂, β̂ and γ̂ that minimize the negative log likelihood
function. In particular, we use algorithm “Nelder-Mead” (Nelder and Mead , 1965),
available in “optim”, which only uses function values for optimization. The initial
values used to start the search are set at 0 for α, β and γ.
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3.4.2 Estimation of Causal Effects
To estimate the conditional NDE and NIE, we need to calculate E{Y (xa,M(xb)} for
given xa and xb. Expectation for outcome E{Y (xa,M(xb)} under eight scenarios are
listed in Table 3.1. The detailed derivations are available in Appendix B.3. Notably,
these causal effects are calculated for a representative individual with mean covariate
values W = w when covariates are continuous, or a stratum W = w when covariates
are categorical. The trivariate Gaussian copula model (3.1)-(3.4) enables us to obtain
some of the eight expectations in the closed forms. In the cases where the closed-forms
expectations are unavailable, we invoke numerical techniques such as “Sparse grid”
or “Monte Carlo” to approximate the integrals in the estimating of causal effects.
3.4.3 Bootstrap for Confidence Interval
Since our estimation procedure is a two-stage profile likelihood estimates and the
expectation of conditional NDE/NIE appear complicated, it is difficult to derive the
standard error of these causal effects using the Delta method (Dorfman, 1938). There-
fore, we propose to adopt the parametric and nonparametric bootstrap approaches
(Efron, 1987), to obtain the 95% confidence intervals (CI) for parameters α, β and γ
as well as the NDE and NIE. In implementation, we generate 500 bootstrap samples,
where we obtain 500 estimates of α, β and γ and NDE and NIE. Then respectively,
a 95% CI is constructed by the 2.5 percentiles and 97.5 percentiles of these 500 em-
pirical estimates. In the parametric bootstrap, 500 bootstrap datasets are generated
from the estimates α̂, γ̂ and γ̂. In the non-parametric bootstrap, these bootstrap
datasets are generated from randomly drawing of the observations with replacement.
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3.5 Three Examples
In this section, we will illustrate how to estimate the conditional NDE and NIE via
the proposed method through three examples with mixed data types. They are,
(i) X, M and Y all follow normal distributions (CCC); (ii) X and Y follow normal
distributions, while M follows Bernoulli distribution (CDC); and (iii) X and M follow
normal distributions, while Y follows Bernoulli distribution (CCD). The proposed
GSEM allows us to obtain the analytic forms of the conditional NDE and NIE for
the first two examples (i) and (ii), and for the third case (iii), we use the Monte
Carlo method to evaluate the integral when the closed forms of causal effects are
unavailable. These three data types illustrated here are commonly encountered in
practice. We present numerical results for these examples in Simulation Studies in
Section 3.6.
3.5.1 Example CCC
In Table 3.1, when X, M and Y are all normally distributed (i.e., as “CCC” case),
conditional NDE and NIE are given below in Proposition III.1.
Proposition III.1. When X and M and Y are normally distributed, the conditional
causal effects for a change of X from x0 to x1 are given by,
NDE(x0, x1; w) =
σyγ(zx1 − zx0)
τy







. Furthermore, we have NDE(x0, x1; w) = 0 if and only if γ = 0.
NIE(x0, x1; w) = 0 if and only if α = 0 or β = 0. This is identical to the causal effect
representation under the classical SEM.




In Table 3.1, when X and Y are continuous, and M is dichotomous (i.e., as “CDC”
case), conditional NDE and NIE are given below in Proposition III.2.
Proposition III.2. When X and Y are normally distributed, and M is binary, the
conditional causal effects for a change of X from x0 to x1 are given by,
NDE(x0, x1; w) =




























, px(w) = Φ(τmum(w) − αx),
dx(w) = φ(τmum(w)−αx). This implies that the sufficient conditions for NDE(x0, x1; w) =
0 are γ = β = 0 or γ = α = 0; NIE(x0, x1; w) = 0 if α = 0 or β = 0.
Note that either α or β must be zero in order for the NDE being zero. This is
because when M is discrete, Zm and M are no longer one-to-one linked. As obvious
in Figure 3.3, when only γ is zero, Zx can change Zm without changing M , Zm can
then change Zy, which leads to a non-zero NDE. To obtain a zero NDE, we need
either γ = α = 0 or γ = β = 0.
3.5.3 Example CCD
In Table 3.1, when X and M are continuous, and Y is discrete (i.e., “CCD” case),
NDE and NIE are given below in Proposition III.3.
Proposition III.3. When X and Y are normally distributed, and M is binary, the
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Figure 3.3: GSEM when X, Y are continuous and M is discrete.
conditional causal effects for a change of X from x0 to x1 are given by,
NDE(x0, x1; w) =
∞∫
−∞
(Φ1(zx0)− Φ1(zx1))π(Z∗m|Zx = zx0)dZ∗m,
















NDE(x0, x1; w) = 0 if and only if γ = 0. This implies that the sufficient conditions
for NIE(x0, x1; w) = 0 are α = 0 or β = 0.
Since both conditional NDE and NIE do not have closed forms, we will resort to









; (ii) plug Z∗m into Φ1(zxa); and (iii) take average
over all the values of Φ1(zxa).
Both conditional NDE(x0, x1; w) and NIE(x0, x1; w) may be interpreted as risk
differences in the case of binary outcome Y . Alternatively, one may interpret these
effects in terms of odds. According to VanderWeele and Vansteelandt (2010), we
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calculate the odds ratios for the conditional NDE and NIE as follows, respectively












m|Zx = zxb)dZ∗m for a = 0, 1 and b = 0, 1.
3.6 Simulation Studies
We carry out four simulation studies to evaluate the performance of the proposed
GSEM methodology. The first study assesses bias, mean squared error (MSE) and
coverage probability of confident interval for causal effects and model parameters.
The second study compares bias, MSE and coverage with an existing method Quasi-
Bayesian Monte Carlo method (QBMC) (Tingley et al., 2014). Both studies were per-
formed to three settings discussed in Section 3.5. The third study concerns the setting
where the outcome is binary and compares the odds ratios calculated from GSEM
and an approximation approach proposed by VanderWeele and Vansteelandt (2010).
The fourth study compares the efficiency of GSEM with the full maximum likelihood
estimation (MLE) procedure, under the setting of CDC with no confounders.
3.6.1 Assessment of GSEM
Consider the three settings: (i) CCC: X, M and Y all follow Normal distributions;
(ii) CDC: X and Y follow Normal distribution, and M follows Bernoulli distribution;
(iii) CCD: X and M follow Normal distribution, and Y follows Bernoulli distribution.
For each setting, we calculate average bias, MSE, and empirical coverage probability
via both parametric bootstrap and non-parametric bootstrap for conditional NDE,
NIE, α, γ and β. The sample size n varies over 200, 500, and 1000. For each sample
size, we run 1,000 replicates. Coverage probability of confidence interval is obtained
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by 500 bootstrap replicates.
The GSEM model is set up according to (3.6) and (3.9), while covariates W =
(W1,W2,W3,W4), and W1 = (W1,W2,W3), with W1 being a column of all ones
for the intercept. Covariates W2,W3,W4 are assumed to follow a multivariate nor-
mal distribution with mean zero and compound symmetry correlation ρw = 0.2 and
standard deviation σw = 0.3. Set βx = (0.5, 0.2, 0.2)
>, βm = (0.8, 0.3, 0.3, 0.4)
>,
βy = (−0.2, 0.4,−0.2, 0.7)>, and σx = σm = σy = 0.3. For the settings (i), (ii)
and (iii), (α, γ, β) take the following values: (0.20, 0.10, 0.20), (0.15, 0.10, 0.75) and
(0.70, 0.10, 0.18).
First, we generate Zx, Zm, Z
∗
m, Zy and Z
∗
y according to (3.6), and then given
true parameters and simulated covariates, we generate exposure X = W>1 βx + σxZx,









(iii) CCD: M = W>βm + σmZ
∗
m, Y = I{Φ(Z∗y ) > 1exp(Wβy)+1}.
We apply the GSEM methodology to first obtain β̂x, β̂m, β̂y, σ̂x, σ̂y, Ẑx, Ẑ
∗
m (or
l̂m and ûm), and Ẑ
∗
y (or l̂y and ûy) through the standard GLM regression, then we
search α̂, β̂, γ̂ by minimizing the negative observed likelihood function. Lastly, we
calculate the estimated NDE and NIE based on parameter estimates α̂, β̂, γ̂.
The simulation results are summarized in Table 3.2. Under the three settings, the
magnitude of average bias for estimation of parameters and causal effects decrease
as the sample size increases. The MSE for n = 1000 is at most one fifth of that for
n = 200 in each setting. The 95% confidence interval have showed coverage rates
for n = 200, 500, 1000 all close to the 95% nominal level using either parametric or
non-parametric bootstrap. The computation cost in the simulation studies is between
30 to 60 minutes for a dataset with 500 sample size under three different settings of
“CCC”, “CDC” and “CDC”.
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Table 3.2: True value, bias, MSE, 95% coverage by parametric bootstrap (PB), and
non-parametric bootstrap (NB) for NDE, NIE, α, γ and β under three
settings. The sample size varies over 200, 500 and 1,000, with 1,000 data
replicates for each sample size. The confidence interval to determine the
coverage is obtained by 500 bootstrap replicates.
Bias (×10−3) MSE (×10−3) Coverage (PB, %) Coverage (NB, %)
Setting True 200 500 1000 200 500 1000 200 500 1000 200 500 1000
NDE 0.10 3.77 1.76 -0.40 4.99 1.97 0.90 94.2 95.0 95.9 94.6 95.1 96.0
NIE 0.04 0.88 0.79 0.71 0.45 0.16 0.08 94.4 94.6 95.0 93.7 94.5 94.6
CCC α 0.20 5.29 2.34 0.54 5.72 2.13 0.98 93.1 94.7 95.6 93.4 94.4 95.1
γ 0.10 4.93 2.05 -0.33 5.41 2.11 0.98 94.0 95.1 95.9 94.5 95.3 96.2
β 0.20 2.66 2.39 3.25 5.75 2.06 1.11 93.5 94.0 93.8 93.7 94.5 93.8
NDE 0.11 0.98 0.97 -0.32 3.96 1.61 0.71 94.6 95.2 95.7 95.3 95.4 96.0
NIE 0.05 3.53 1.53 0.46 1.46 0.55 0.24 93.3 93.4 94.3 93.7 93.0 94.4
CDC α 0.15 8.31 2.59 0.67 10.23 3.84 1.68 93.3 94.1 95.0 93.8 93.3 94.9
γ 0.10 0.69 0.96 -0.52 8.01 3.15 1.32 94.7 94.1 95.2 93.9 94.2 95.4
β 0.75 22.84 13.96 4.04 20.07 6.74 3.43 92.8 94.7 94.4 93.6 95.1 94.5
NDE 0.13 5.40 0.80 0.59 21.03 8.01 4.00 93.7 94.2 94.6 94.1 94.1 94.2
NIE 0.14 3.70 1.64 1.25 5.45 2.17 1.05 94.7 93.6 94.4 94.6 94.4 94.5
CCD α 0.70 9.22 5.64 3.54 7.56 3.09 1.65 94.7 94.8 93.6 93.3 94.5 94.0
γ 0.10 5.36 0.89 0.67 14.15 5.21 2.57 93.8 94.0 94.8 94.4 93.9 94.4
β 0.18 7.24 2.53 1.92 9.33 3.48 1.71 93.8 93.7 94.2 93.5 94.6 94.5
3.6.2 Comparison to QBMC
In the second simulation study, we compare the coverage probability and MSE be-
tween our proposed GSEM method and the “mediation” R package (Tingley et al.,
2014; Imai et al., 2010a), a quasi-Bayesion Monte Carlo simulation-based method
(in short, QBMC). The comparison is conducted under two scenarios: one under
datasets being generated from the GSEM, and the other from the QBMC. We focus
on assessing their performance for conditional NDE and NIE equal to zero, and not
zero.
The GSEM model specification is the same as discussed in Section 3.6.1. Let
βx = (0.5, 0.2, 0.2)
>, βm = (0.8, 0.3, 0.3, 0.4)
>, βy = (−0.2, 0.4,−0.2, 0.7)>, and σx =
σm = σy = 0.3. For the null effects, (α, γ, β) takes the following values: (0.30, 0, 0)
>,
(0.15, 0, 0)> and (0.70, 0, 0)>. According to the propositions discussed in Section 3.5,
the conditional NDE and NIE are both zero in these three settings. For the non-
zero causal effects, (α, γ, β) takes values (0.20, 0.10, 0.20)>, (0.15, 0.10, 0.75)> and
(0.70, 0.10, 0.18)>.
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The QBMC model is set up as follows: X is simulated from N(W>1 βx, σX), then
M and Y are generated for the following three settings: (i) CCC: M = βxmX +
W>βm + εM , Y = βxyX + βmyM + W
>βy + εY ; (ii) CDC: logit(P (M = 1)) =
βxmX + W
>βm, Y = βxyX + βmyM + W
>βy + εY ; and (iii) CCD: M = βxmX +
W>βm + εM , logit(P (Y = 1)) = βxyX + βmyM + W
>βy, where σX = σM =
σY = 0.3, βx = (0.5, 0.2, 0.2)
>, βm = (0.5, 0.2, 0.2, 0.4)
>, βy = (−0.8, 0.2,−0.5, 0.4)>.
For settings (i) through (iii), (βxm, βxy, βmy)
> take the following values (0.30, 0, 0)>,
(0.30, 0, 0)> and (0.30, 0, 0)> for null effects, and (0.20, 0.10, 0.20)>, (0.40, 0.10, 0.50)>
and (0.70, 0.50, 0.70)> for non-zero effects.
Table 3.3 summarizes the comparison results between GSEM and QBMC under
the criteria of empirical coverage probability, average bias and MSE. When the data
are generated from the GSEM, the coverage rates of GSEM are closer to the nominal
95% level in most cases. For average bias and MSE, the GSEM has shown advantages
in some cases, such as CCD where the GSEM consistently provides smaller bias and
MSE for NIE, no matter the true effects are zeros or not, compared to QBMC. In the
CDC case, the GSEM provides smaller bias for NIE and NDE compared to QBMC
when sample size n = 500 and the true effects are not zero. For the other cases, the
results between the two methods are comparable.
When the data are generated from QBMC and effects are zero, two methods are
comparable. When the effects are not zero, since the QBMC method does not provide
formula to calculate the true effects, the true effects are estimated from a dataset
with a very large sample n = 100, 000, under which the estimated effects from the R
package are then used as true effects. So the comparison under the non-zero effect
setting needs to be interpreted cautiously.
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Table 3.3: Coverage via the parametric bootstrap, bias and MSE comparison of
GSEM and QBMC. When data are generated from GSEM, (α, γ, β)>
takes values (0.30, 0, 0)>, (0.15, 0, 0)> and (0.70, 0, 0)> under zero NDE and
NIE; and (0.20, 0.10, 0.20)>, (0.15, 0.10, 0.75)> and (0.70, 0.10, 0.18)> un-
der non-zero NDE and NIE. Similarly, when data are generated from SEM,
(βxm, βxy, βmy)
> takes values (0.30, 0, 0)>, (0.30, 0, 0)> and (0.30, 0, 0)>
under zero NDE and NIE; and (0.20, 0.10, 0.20)>, (0.40, 0.10, 0.50)> and
(0.70, 0.50, 0.70)> under non-zero NDE and NIE. The sample size varies
over 200 and 500, with 1,000 data replicates for each sample size.
Coverage (%) Bias (×10−3) MSE (×10−3)




GSEM 95.0 94.6 -1.70 3.62 5.82 2.31
QBMC 95.4 94.4 -1.68 3.59 5.67 2.27
NIE 0
GSEM 92.6 94.3 -0.30 -0.37 0.58 0.20
QBMC 93.2 94.0 -0.26 -0.36 0.54 0.20
NDE 0.10
GSEM 95.3 94.8 -0.56 3.89 5.13 2.06
QBMC 95.4 94.0 -1.74 3.37 5.03 2.03
NIE 0.04
GSEM 94.0 94.6 1.28 -0.12 0.47 0.16
QBMC 94.0 94.7 -0.03 -0.65 0.44 0.16
CDC
NDE 0
GSEM 95.1 94.0 -1.97 3.40 5.24 2.12
QBMC 95.1 93.8 -1.96 3.35 5.07 2.09
NIE 0
GSEM 97.8 96.0 -0.02 -0.15 0.12 0.04
QBMC 98.7 96.9 0.02 -0.12 0.10 0.03
NDE 0.11
GSEM 93.9 94.2 -1.87 2.23 4.18 1.64
QBMC 94.2 94.3 0.51 4.30 4.14 1.66
NIE 0.05
GSEM 93.9 95.0 3.01 0.05 1.37 0.49
QBMC 96.0 95.5 -2.77 -3.33 1.08 0.42
CCD
NDE 0
GSEM 96.0 95.4 9.14 1.03 19.94 7.70
QBMC 96.6 95.9 9.68 1.86 17.23 7.13
NIE 0
GSEM 94.0 94.3 -6.63 -0.12 4.82 1.82
QBMC 95.4 95.0 -8.28 -0.83 5.82 2.44
NDE 0.13
GSEM 95.4 94.6 6.42 1.63 19.35 7.84
QBMC 95.5 94.9 1.39 -1.96 16.74 7.20
NIE 0.14
GSEM 93.6 95.0 -0.90 0.87 5.51 2.10




GSEM 95.0 94.6 -1.70 3.62 5.82 2.31
QBMC 95.5 94.5 -1.68 3.59 5.67 2.27
NIE 0
GSEM 92.6 94.3 -0.30 -0.37 0.58 0.20
QBMC 93.4 93.9 -0.26 -0.36 0.54 0.20
NDE 0.10
GSEM 95.3 94.0 3.80 8.38 5.45 2.24
QBMC 95.1 94.6 2.59 7.85 5.33 2.20
NIE 0.04
GSEM 93.6 94.2 -0.26 -1.70 0.49 0.17
QBMC 93.7 93.4 -1.61 -2.25 0.47 0.17
CDC
NDE 0
GSEM 94.0 93.9 -4.06 -0.98 5.16 2.06
QBMC 95.2 94.1 -4.14 -0.96 5.02 2.03
NIE 0
GSEM 99.5 99.3 0.34 -0.02 0.05 0.01
QBMC 99.9 99.6 0.34 -0.02 0.04 0.01
NDE 0.09
GSEM 93.6 94.0 5.24 7.49 5.28 2.17
QBMC 95.7 93.5 1.95 5.13 5.01 2.05
NIE 0.04
GSEM 93.5 93.6 5.41 3.76 3.32 1.23
QBMC 95.7 96.7 5.41 4.83 3.31 1.24
CCD
NDE 0
GSEM 94.3 94.2 1.08 3.93 13.72 5.42
QBMC 95.6 94.5 1.91 4.10 12.72 5.21
NIE 0
GSEM 93.7 95.1 -2.71 -0.79 1.17 0.40
QBMC 95.2 94.8 -3.41 -1.21 1.10 0.42
NDE 0.12
GSEM 94.3 95.3 11.24 7.20 21.25 8.26
QBMC 95.0 95.5 5.36 3.70 18.25 7.63
NIE 0.12
GSEM 94.2 93.2 -21.14 -18.14 5.46 2.19
QBMC 95.7 96.5 -12.30 -4.60 5.75 2.31
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3.6.3 Odds Ratio comparison for Binary Outcome
In the third simulation study, we consider the “CCD” case where X and M are
continuous and Y is binary. The NDE and NIE on the odds ratio scale are compared
by GSEM according to (3.11), and an alternative approximation approach proposed
by VanderWeele and Vansteelandt (2010), which is termed as “VV” method in short.
In particular, we consider two scenarios: rare outcome (around 4% of outcomes being
“1”) and abundant outcome (around 45% of outcomes being “1”).
For both types of outcomes, data are generated from GSEM, with βx = ({0.5, 0.2, 0.2)>,
βm = (0.8, 0.3, 0.3, 0.4)
>, α = 0.70, γ = 0.10 and β = 0.18. For the case of
rare outcome, βy = (−0.2, 0.4,−0.2, 0.7)>, and for the case of abundant outcome,
βy = (−3.0, 0.4,−0.2, 0.7)>. Covariates W and W1 and variance parameters are set
the same as those in the first and second simulation studies.
Table 3.4: True value, mean bias, MSE comparison of ORNDE and ORNIE for meth-
ods GSEM and “VV”. Data are generated from GSEM, sample size varies
over 500, 1,000, and 2,000 with 1000 data replicates for each sample size.
Bias MSE
Setting Odds Ratio True Method 500 1000 2000 500 1000 2000
Abundant
ORNDE 1.704
GSEM 0.116 0.098 0.022 0.573 0.250 0.091
VV 0.134 0.114 0.035 0.600 0.264 0.095
ORNIE 1.762
GSEM 0.070 0.026 0.017 0.136 0.056 0.027
VV 0.315 0.251 0.238 0.349 0.166 0.105
Rare
ORNDE 2.169
GSEM 1.135 0.662 0.290 22.062 5.109 1.629
VV 0.618 0.350 0.078 10.039 2.870 1.055
ORNIE 2.113
GSEM 0.502 0.157 0.087 2.662 0.660 0.280
VV 0.830 0.490 0.421 3.610 1.194 0.591
As shown in Table 3.4, for the case of abundant events, “VV” has a larger mag-
nitude of average bias and MSE than GSEM for the odds ratio of NDE and NIE. For
the case of rare events, “VV” has smaller bias and MSE for the odds ratio of NDE,
but larger bias and MSE for the odds ratio of NIE. One explanation for the poor
performance of GSEM on NDE might be that for rare events, the GLM may generate
large bias due to the instability of the numerical algorithm. Nevertheless, GSEM still
provides a better performance compared to “VV” method on the odds ratio of NIE.
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For abundant events, GSEM clearly demonstrates the advantage over “VV”.
3.6.4 Efficiency comparison with MLE
Given that GSEM is a framework based on inference functions for margins (IFM),
a two-stage likelihood estimation method, in this simulation study we are interested in
comparing GSEM with the full maximum likelihood estimation approach to evaluate
the relative efficiency. For simplicity, we consider the CDC setting without confound-
ing factors. The dataset is generated under a GSEM model with α = 0.25, γ = 0.50,
β = 0.75; βx = 0.50 and βy = −0.20 for mean parameters of X and Y ; βm = 0.80 for
log odds ratio of M ; and σx = σy = 0.30 for variance parameters of X and Y . The full
MLE procedure is performed with the R function “optim” to simultaneously search
for the estimates of the aforementioned eight parameters. Table 3.5 reports the com-
parison results of empirical variance, relative efficiency defined by Variance of GSEM
Variance of MLE
,
mean bias and MSE for α, γ and β from 1,000 simulated datasets. GSEM has slightly
larger variance for α and γ then MLE, leading to less than one percent of efficiency
loss. For bias and MSE, GSEM in general provides larger bias and MSE compared
to the full MLE approach.
Table 3.5: Variance, relative efficiency, bias and MSE comparison of GSEM and MLE
under the setting of CDC. When data are generated from GSEM. Relative
efficiency (Rela. Efficiency)=Variance of GSEM
Variance of MLE
. The sample size varies
over 200 and 500, with 1,000 data replicates for each sample size.
Variance (×10−3) Rela. Efficiency Bias (×10−3) MSE (×10−3)
Parameter True Method 200 500 200 500 200 500 200 500
α 0.25
GSEM 9.986 3.767 99.66% 99.82% 10.005 2.929 10.076 3.772
MLE 9.951 3.761 - - 8.578 2.372 10.015 3.763
γ 0.50
GSEM 9.719 3.375 99.46% 99.82% 3.474 1.432 9.721 3.373
MLE 9.666 3.369 - - 1.682 0.717 9.659 3.366
β 0.75
GSEM 17.884 6.626 100.00% 100.00% 18.527 0.994 18.209 6.621
MLE 17.887 6.630 - - 17.848 0.707 18.188 6.624
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3.7 Data Application
In this section, we present a data analysis of the motivating data example from the
ELEMENT cohort study, see the detail of the data example in Section 3.2. We
hypothesize the association between phthalate exposures during mothers’ second and
third trimesters and cardiometabolic outcomes of children in peripuberty may be
mediated by the timing of children reaching their infancy BMI peaks on time (M = 0)
or delayed (M = 1).
Exposures X include six maternal urinary phthalate concentrations of MEHHP,
MEOHP and MIBP measured at second trimester (T2) and third trimester (T3).
Exposure X appears right skewed, so a logorithm transformation of X is taken, and
log(X) is appearing normally distributed. Outcomes Y include three standardized
z-scores of health outcomes measured during adolescence, including fasting glucose
z-score, C-peptide z-score, and MetS z-score. The outcome Y appears normally dis-
tributed. The mediator of reaching infancy BMI peak on time or not is binary where
27.8% of children have delayed infancy BMI peak time. Confounders W1 include
mother’s age at birth, education, and marital status, which affect the exposures, me-
diator and outcomes. Confounders W2 include breastfeeding duration, parity, child’s
gender, gestational age, and birth weight, a set of factors that only affect the mediator
and outcomes.
We fit the dataset by GSEM discussed in Section 3.5.2, where W1 are confounders
for X, and {W1,W2} are confounders for M and Y in our model (3.9). We first
estimate the model parameters and causal effects, then obtain 95% CI for conditional
NDE, NIE and TE through the parametric bootstrap. From the results summarized in
Table 3.6, we found that a positive NIE with an estimate of 0.015 and 95% CI (0.001,
0.026) for MEHHP during the second trimester on MetS z-score, suggesting that one
unit increase in exposure to MEHHP during the second trimester would result in
an increase of 0.015 in MetS z-score, which is mediated through the BMI infancy
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peak. Similarly, a positive NIE with an estimate of 0.017 and 95% CI (0.001, 0.032)
was identified for MEOHP during the second trimester on MetS z-score. However,
both NDE and TE are not statistically significant for these two exposures on the
MetS z-score. We will interpret the significant NIE results as the pathway mediation
analysis.
Table 3.6: NDE, NIE and TE estimates and 95 % CI obtained from GSEM for ELE-
MENT study.
Exposure Outcome NDE 95% CI NIE 95% CI TE 95% CI
MEHHP T2
glucose -0.013 (-0.121, 0.105) 0.016 (-0.001, 0.035) 0.003 (-0.109, 0.116)
C-peptide -0.098 (-0.219, 0.031) 0.014 (-0.003, 0.032) -0.084 (-0.205, 0.038)
MetS -0.067 (-0.133, 0.004) 0.015 (0.001, 0.026) -0.051 (-0.120, 0.016)
MEOHP T2
glucose -0.011 (-0.130, 0.100) 0.017 (-0.002, 0.038) 0.006 (-0.115, 0.116)
C-peptide -0.105 (-0.236, 0.016) 0.015 (-0.003, 0.034) -0.090 (-0.227, 0.032)
MetS -0.071 (-0.134, 0.005) 0.017 (0.001, 0.032) -0.054 (-0.118, 0.022)
MIBP T2
glucose 0.038 (-0.078, 0.150) 0.014 (-0.007, 0.044) 0.052 (-0.053, 0.168)
C-peptide -0.019 (-0.128, 0.097) 0.011 (-0.007, 0.038) -0.008 (-0.117, 0.108)
MetS -0.020 (-0.084, 0.053) 0.013 (-0.005, 0.041) -0.007 (-0.073, 0.069)
MEHHP T3
glucose 0.053 (-0.069, 0.163) 0.006 (-0.013, 0.022) 0.059 (-0.066, 0.168)
C-peptide 0.017 (-0.104, 0.137) 0.005 (-0.014, 0.020) 0.022 (-0.098, 0.142)
MetS 0.005 (-0.069, 0.077) 0.005 (-0.016, 0.017) 0.011 (-0.066, 0.081)
MEOHP T3
glucose 0.055 (-0.071, 0.184) 0.003 (-0.022, 0.022) 0.058 (-0.067, 0.188)
C-peptide 0.033 (-0.093, 0.173) 0.003 (-0.017, 0.017) 0.035 (-0.089, 0.175)
MetS 0.009 (-0.065, 0.091) 0.003 (-0.020, 0.018) 0.013 (-0.062, 0.091)
MIBP T3
glucose 0.106 (-0.027, 0.257) 0.013 (-0.008, 0.039) 0.118 (-0.012, 0.266)
C-peptide 0.020 (-0.126, 0.179) 0.011 (-0.009, 0.039) 0.030 (-0.110, 0.184)
MetS -0.014 (-0.099, 0.087) 0.012 (-0.008, 0.032) -0.001 (-0.093, 0.102)
For sensitivity analysis, we perform the same analysis stratified on gender. For
boys, the sample sizes for the second trimester and the third trimester exposures are
79 and 96; for girls, the same sample sizes are 98 and 106. The stratified analyses
were presented in Table B.2 for boys and Table B.3 for girls in Appendix B.4. For
boys, none of the effects are found to be significant, likely due to the small sample
size. For girls, a significant NIE is identified for MIBP exposure during the second
trimester on MetS z-score.
Another sensitivity analysis is performed to examine the effect of breastfeeding
duration, a continuous variable about how many months that a mom had been breast-
feeding her child. In previous analyses, we assume that breastfeeding duration is a
confounder for mediator and outcome and the breastfeeding duration is not affected
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by exposures X. This is one of the key assumptions for the identifications of natural
effects. However, it is possible that breastfeeding could be influenced by exposures and
then influences the BMI infancy peak, making it a potential mediator. Therefore, we
perform the same analysis again without including the breastfeeding as a confounder
to examine how different the results are with and without including breastfeeding.
Table B.1 in Appendix B.4 summarizes the results for the sensitivity analysis exclud-
ing breastfeeding. Compare it with Table 3.6, we can see that the effect estimates
are very similar, and the NIE remains significant for second trimester exposures to
MEOHP and MIBP on MetS z score.
3.8 Concluding Remarks
This chapter developed a new framework for mediation analysis, GSEM, when ex-
posure X, mediator M and outcome Y are of mixed types. We proposed a unified
framework of hierarchical GSEMs based on the Gaussian copula models, which allows
us to specify the joint density of X, M and Y using a hierarchical modeling approach.
The GSEMs provide a flexible modeling of causal effects for mixed data types. The
proposed GSEM characterizes interpretable parameters α, β and γ. We illustrated
the GSEM methodology through three specific examples of practical importance.
Through extensive simulation studies, the proposed profile likelihood estimation can
accurately make statistical inference on NDE and NIE under the model assumptions.
Modeling X, M and Y respectively given covariates W allows us to potentially
handle the high dimensional covarites easily and efficiently. In contrast, the conven-
tional structural equation modeling involves both the parameters for causal effects
and high-dimensional nuisance parameters for the confounding effects, leading to a
complicated inference procedure. The ability to handle the high-dimensional covari-
ates easily is especially critical as one of the core assumptions under the potential
outcome framework is “sequential ignorability” meaning that we must include all the
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possible confounders in order to identify the conditional causal effects (VanderWeele
and Vansteelandt , 2009).
The current procedure focuses mainly on the estimation of the causal effects. To
make inference about the causal effects, we need to develop formal statistical testing
procedures to address the issue of composite null hypothesis. This is a challenging as
it would be a composite task, which is our future work. We plan to extend the cur-
rent framework of single mediator to multi-mediators of mixed types. There are some
methods developed for continuous multi-mediators. However, there lack methodolog-
ical developments for multi-mediators of mixed types. The flexibility of the copula
dependent model allowing the different types of marginal distributions can provide
a useful tool to handle the multi-mediators of mixed data types. Another potential
future work is to adopt the current GSEM framework and extend it to accommo-
date multiple mediators with mixed data types. As seen in our real data application,
the BMI infancy peak is a binary mediator and breastfeeding duration is potential
a continuous mediator, and currently there is a lack of methods to analyze multiple
mediators of mixed types. The flexibility of copula dependence models that handle




Mediation Pathway Analysis with Categorical
Exposure Variable
4.1 Introduction
Causal mediation analysis via the structural equation modeling (SEM) approach has
been widely used in many scientific disciplines, such as social sciences, epidemiology,
environmental health sciences and so on. Baron and Kenny (1986) first proposed the
mediation analysis under the linear regression framework, and more recent literature
has focused on the potential outcome framework (Robins and Greenland , 1992; Pearl ,
2001), in which the concepts of direct and indirect effects have been extended to
natural direct effect (NDE) and natural indirect effect (NIE).
In the SEM setting as shown in Figure 1.1, when both mediator M and outcome
Y are continuous and normally distributed, the assessment of the NDE and NIE are
well studied via the decomposition TE=NDE+NIE, see more details in (VanderWeele
and Vansteelandt , 2009). Since exposure X is a dependent variable in both regression
models of SEM, X can be either continuous or categorical. In this chapter, we focus
on the case where exposure X is binary, such as a treatment variable with active
drug and placebo. In this case, we are interested in assessing the causal effects of the
treatment on an outcome of interest.
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In this chapter, we focus on two important cases of binary exposure. The first
case concerns the scenarios of drug absorption rate, an issue of effective drug dose.
Our motivating example is a birth cohort study, “The Early Life Exposures in Mexico
to ENvironmental Toxicants” (ELEMENT), which recruited three mother-child pairs
from Mexico City during mid-90s. The overarching goal of this cohort study is to
understand how environmental toxicants, such as phthalates, phenols and metals
affect mother and child health outcomes, such as birth weight. Of those toxicants,
exposure to lead is especially concerning as in-utero lead exposure may lead to low
birth weight and developmental delay in offspring (Zhu et al., 2010). A randomized
control trial in the ELEMENT cohort was conducted to investigate whether maternal
calcium supplementation helps suppress the release of the bone lead to the blood,
which in turn may reduce offspring’s exposure to lead during pregnancy (Perng et al.,
2019). In this chapter we plan to examine whether, and to what extent, the effect
of calcium supplementation on birth weight is mediated by the mother’s blood lead
concentration during third trimester of pregnancy.
In this motivation example, we argue that even though mothers are allocated in the
same treatment group, their individual absorption of calcium capacity is very likely to
vary from person to person. It is practically unrealistic to obtain direct measurements
of absorption. Thus, using binary exposure in the SEM is an approximation , ignoring
the individual-level calcium dose. To fill this gap, we propose a new model, termed as
effective dose model, a latent exposure variable Z is introduced to capture the effective
dose of the treatment in the analysis of effective degree of those causal effects. Figure
4.1 describes a DAG with observed treatment variable (X), latent absorbed dose of
calcium (Z), mediator maternal blood lead (M), and outcome birth weight (Y ).
As a scientific premise, we hypothesize that for mothers allocated to the control group
(X = 0), their effective dose of calcium Z = 0; for mothers allocated to calcium group
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Figure 4.1: Hypothesized causal associations among calcium absorbed, maternal
blood lead and birth weight.
(X = 1), their absorbed dose of calcium Z follows a truncated normal distribution,
denoted by TN(a, 1), which only takes positive values and a > 0. Here, we see
Z = (1 − X)I[Z = 0] + XTN(0,+∞)(a, 1). The known value a describes the mean
absorption rate for an individual. The higher the value a, the higher the subject’s
absorption of calcium. The subject specific ai is assumed to have been obtained
from external data, such as Phase I clinical trials that measure the pharmacokinetic
dynamics of the drug. ai can be modeled by statistical modeling characterizing the
individual specific absorption rate. We believe this latent dose variable of calcium can
more accurately describe effective exposure than a binary treatment variable. The
conventional binary treatment variable X can be viewed as an approximation to the
effective dose variable Z. While using a binary exposure X in a mediation analysis
gives rise to certain simplicity, it indeed poses an assumption of the same dosage for
individuals in the calcium group in the evaluation of causal effects. Specially, this
assumption implies that the treatment effect on the outcome is linear, and ignores
the individual variability in the absorption of calcium. Adopting Z instead of X in
the mediation analysis allows us to obtain better examination of causal mediation
pathways.
59
Let us discuss another important case of binary exposure. In some observational
studies, often we only observe a binary exposure which arises from a continuous under-
lying unobserved exposure variable, by the means of dichotomization. For example,
in electronic health records data, patient’s diabetes diagnosis is commonly recorded
as a binary variable of yes or no, but his/her fasting glucose levels measured by the
lab are not available. In fact, the diagnosis of diabetes (X = 1) means his/her fast-
ing glucose level is 126 mg/dl or higher. For all the diabetes patients, their glucose
levels can vary substantially, and the information of severity provides more critical
medical condition than a dichotomous disease status. The aforementioned effective
dose scenario is not the same this type of binary exposure. Therefore, we propose
another dichotomization model, in which a latent exposure variable is introduced to
determines an observed binary exposure variable X. In the diabetes example, con-
ceptually we can map the glucose level to a standardized latent z-score variable Z,
X = I(Z > 0).
Under the two proposed binary exposure models, we investigate both NDE and
NIE in the causal mediation pathways. Along this line, we propose an extension
under the latent variable model, leading to the new concepts of generalized natural
direct/indirect effects (GNDE/GNIE). We demonstrate that GNDE and GNIE are
more desirable to quantify and interpret causal mediation effects than the conven-
tional NDE and NIE (Pearl , 2001).
The remainder of the chapter is organized as follows. Section 4.2 introduces
two new frameworks of effective dose model and latent exposure model. Section 4.3
presents the formulation of NDE and NIE, which is then extended into the new con-
cepts to GNDE and GNIE. Section 4.4 discusses the maximum likelihood estimation
procedure for the model parameters and effects, as well as their confidence intervals.
Section 4.5 presents simulation studies to examine the numerical behaviours of the
two proposed models. Section 4.6 is devoted to the data application of the calcium
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supplementation trial from ELEMENT study. Section 4.7 includes some concluding
remarks on advantages and limitations of the proposed methodologies. Technical
details can be found in Appendix C.
4.2 Method
This section presents two new models to describe the potential data generating mech-
anism of binary exposure. As a result, we generalize the definitions of the classical
natural direct effect and natural indirect effect. These new concepts can provide
better understanding and interpretation of the underlying intrinsic causal mechanism
among binary exposure X, mediator M and outcome Y .
4.2.1 Effective Dose Model
We now present the effective dose model. Consider a randomized trial in that the
allocation of treatment or exposure X follows a Bernoulli distribution with probability
p = 0.5. Assume Z is a latent variable that represents the effective dose of the
treatment that a subject would absorb. For a subject in the control arm (X = 0), the
dose Z variable is naturally equal to 0; for a subject in the active drug arm (X = 1),
the dose variable Z is assumed to follow a truncated normal distribution with mean
a (a > 0) and variance 1 due to the fact that it takes positive values on the interval
(0,∞), denoted as TN(0,∞)(a, 1). Hence, the marginal distribution of Z is a mixture
of point mass function at 0 and truncated normal distribution taking positive values;
namely Z | X = (1−X)I[Z = 0] +XTN(0,+∞)(a, 1). To form a structured equation
model (SEM) in a mediation analysis, we assume that continuous mediator M is
normally distributed with mean αZ and variance σ2M , and that a continuous outcome
Y is normally distributed with mean γZ + βM and variance σ2Y . Apparently, the
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effective dose model is used to expand the commonly used SEM as follows:
X ∼ Bern(p = 0.5), [Z | X] ∼ (1−X)I[Z = 0] +XTN(0,∞)(a, 1),
[M | Z ] ∼ N(αZ, σ2M), [Y | Z,M ] ∼ N(γZ + βM, σ2Y ), (4.1)
where a is pre-specified mean absorption rate of calcium.
4.2.2 Latent Exposure Model
We now turn to the latent exposure model for binary exposure X that arises from
dichotomization. Assuming that a latent continuous exposure variable Z follows a
normal distribution with mean µ and variance 1, we only observe a binary exposure
variable X that is dichotomized from continuum Z. Exposure X may be interpreted
as an observed categorical variable of the latent Z. Similar to effective dose model
above, there exists a latent variable Z of the underlying exposure. The latent exposure
model takes the following form:
Z ∼ N(µ, 1), [X | Z ] = I(Z > 0),
[M | Z ] ∼ N(αZ, σ2M), [Y | Z,M ] ∼ N(γZ + βM, σ2Y ). (4.2)
4.3 Mediation Pathway Analysis
Given two models (4.1) and (4.2), we now derive the natural direct effect (NDE)
and natural indirect effect (NIE). The details of the derivations can be found in
Appendix C.1. As a result, we are able to generalize these classical concepts; we
define the generalized natural direct effect (GNDE) and generalized natural indirect
effect (GNIE) based on the latent exposure models (4.1) and (4.2). We discuss some
connections of the new concepts to the classical NDE and NIE.
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4.3.1 Natural Direct and Indirect Effects
Let us begin with the potential outcome framework from the causal inference lit-
erature (Robins and Greenland , 1992; Pearl , 2013; VanderWeele and Vansteelandt ,
2009). Adopting the counterfactual notions (VanderWeele and Vansteelandt , 2009),
let Y (x,m) denote the counterfactual outcome that would have been observed for the
subject had the exposure X been set to value x and mediator M to value m; let M(x)
be the counterfactual value of mediator had the exposure X been set to value x. By
definition, E{Y (xa,M(xb))} is the expected outcome of Y had the exposure been set
to value xa and mediator been set to value M(xb), and moreover we have
E{Y (xa,M(xb))} = EM [EY {Y |M,X = xa}|X = xb].
According to VanderWeele and Vansteelandt (2009), the natural direct effect (NDE),
the natural indirect effect (NIE), and the total effect (TE) for a change of X from x0
to x1 are given by, respectively,
NDE(x0, x1) = E{Y (x1,M(x0))} − E{Y (x0,M(x0))},
NIE(x0, x1) = E{Y (x1,M(x1))} − E{Y (x1,M(x0))},
TE(x0, x1) = E{Y (x1,M(x1))} − E{Y (x0,M(x0))}.
Proposition IV.1. Under the Effective Dose Model (4.1), the causal effects for

















































) . Moreover, we have the following sufficient conditions: if
γ = 0, then NDE = 0; if α = 0 or γ = β = 0, then NIE = 0.
Proposition IV.2. Under the Latent Exposure Model (4.2), the causal effects

























































) . Moreover, we have the fol-
lowing sufficient conditions: if γ = 0, then NDE = 0; if α = 0 or γ = β = 0, then
NIE = 0.
4.3.2 Generalized Natural Direct and Indirect Effects
Alternatively, we focus on causal effects under latent exposure models (4.1) and (4.2),
with a change of Z from za to zb:
E{Y (Za,M(Zb))} = EM [EY {Y |M,Z = za}|Z = zb].
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We term the resulting NDE/NIE/GTE as Generalized Natural Direct/Indirect/Total
Effects. Precisely, for a change of Z from z0 to z1, GNDE, GNIE and GTE defined
given by, respectively
GNDE(z0, z1) = E[Y (z1,M(z0)]− E[Y (z0,M(z0)],
GNIE(z0, z1) = E[Y (z1,M(z1)]− E[Y (z1,M(z0)],
GTE(z0, z1) = E[Y (z1,M(z1)]− E[Y (z0,M(z0)].
Since the causal effects are to make a comparison between treatment group and
control group, let z0 represent a possible latent value for a subject in the control
group (X = 0), and let z1 represent a latent value for a subject in the treatment
group (X = 1). This means that for the effective dose model (4.1), all z0 values equal
to 0.
Proposition IV.3. Under the Effective Dose Model (4.1), the generalized causal
effects for a change of Z from z0 = 0 to z1 are given by, respectively
GNDE(z0, z1) = γ(z1 − z0) = γz1, GNIE(z0, z1) = αβ(z1 − z0) = αβz1,
where z1 = E(Z | X = 1) = a+ φ(a)Φ(a) . Moreover, we have the sufficient and necessary
conditions: GNDE = 0 if and only if γ = 0; GNIE = 0 if and only if α = 0 or β = 0.
Proposition IV.4. Under the Latent Exposure Model (4.2), the generalized
causal effects for a change of Z from z0 to z1 are given by, respectively
GNDE(z0, z1) = γ(z1 − z0), GNIE(z0, z1) = αβ(z1 − z0),
where z1 − z0 = E(Z | X = 1)− E(Z | X = 0) = φ(µ)Φ(µ)(1−Φ(µ)) . Moreover, we have the
sufficient and necessary conditions: GNDE = 0 if and only if γ = 0; GNIE = 0 if
and only if α = 0 or β = 0.
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For both latent models for binary exposure (4.1) and (4.2), the parameter γ char-
acterizes GNDE, while α and β characterize GNIE. Their interpretation are identical
to those given in the classical SEM setting. In contrast to the sufficient conditions for
NIE = 0 in Propositions IV.1 and IV.2, parameter γ determines the NIE. These are
not necessary conditions. The new concepts of GNDE and GNIE apparently provide
better interpretations of causal effects for the roles of parameters α, β and γ.
4.4 Estimation
This section presents the estimation of parameters and causal effects under both
models. Due to the involvement of the latent exposure variable, the key step is to
derive the observed data likelihood by integrating out the latent exposure variable
Z. Then, by minimizing the negative log-likelihood function, we obtain parameter
estimates, using the R function “optim”. In particular, we use the algorithm “L-
BFGS-B” (Byrd et al., 1995) for the optimization. This algorithm allows us to specify
the lower and/or upper bounds of the parameters, such as the constraints σ2M > 0
and σ2Y > 0.
Standard errors of the model parameter estimates are computed from the Fisher
Information matrix, and standard errors of the generalized causal effects are obtained
via the delta method (Dorfman, 1938). Consequently, a 95% confidence interval
(CI) is constructed under the standard large-sample theory of maximum likelihood
estimation (MLE), with point estimates and their standard errors.
4.4.1 Observed Likelihood in Effective Dose Model
Some key steps required by the calculation of the observed log likelihood function are
given in this section. Consider a dataset consist of n observations (Xi,Mi, Yi), as well
as the latent variable Zi, defined in model (4.1). The complete data likelihood for
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subject i is given by
π(Yi,Mi, Zi | Xi) = π(Yi |Mi, Zi)π(Mi | Zi)π(Zi | Xi),
where π(·) is a generic notation of a density function.
When Xi = 0,
















When Xi = 1,
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I(Xi = 1) is the total number of subjects in the treatment group. We
minimize the negative log-likelihood function −`(θ) by the algorithm “L-BFGS-B”
with respect to model parameters α, γ, β, σ2M and σ
2
Y , and obtain the parameter
estimates. The initial values to start the search are set at α̂(0) = 0, γ̂(0) = 0, β̂(0) = 0,
σ̂
2(0)
M = v̂ar(M), σ̂
2(0)
Y = v̂ar(Y ).
4.4.2 Observed Likelihood in Latent Exposure Model
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,
where densities π(Mi, Yi) and π(Zi | Mi, Yi) can be straightforwardly obtained from
(4.5). We then minimize the negative log-likelihood function −`(θ) by the algorithm




Y to obtain the parameter estimates. The initial values α̂





Y are given by the moment estimates. In particular, µ̂
(0) is estimated by the
quantile of the standard normal distribution with the probability equal to the observed




let Zi = µ̂
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M , and σ̂
2(0)
Y are obtained by fitting the two regression models in (4.2).
4.5 Simulation
We carry out extensive simulations to evaluate the performance of the MLE in the
two proposed models (4.1) and (4.2). In particular, we calculate average bias, mean
square error (MSE), empirical coverage of 95% confidence interval, empirical standard
error (ESE) of ML estimates, and average standard error (ASE) of estimates for both
parameters and causal effects. Let θ̂j be estimate of a parameter θ under the j-th
simulated dataset, where J denotes the total number of datasets. Let θ0 be the true
value. Then average bias is 1
J
∑J




























where se(θ̂j) is the standard error calculated from the Fisher Information matrix.
The sample size n varies over 200, 500 and 1000, and for each sample size, we
generated J = 10, 000 datasets.
4.5.1 Simulation with Effective Dose Model
Binary exposure variable Xi is first simulated from a Bernoulli distribution with
probability 0.5. When Xi = 0 is generated, Zi = 0; when Xi = 1, Zi is drawn from
a truncated normal distribution with mean ai = 0 and variance 1 on interval (0,∞).
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Then, we generate mediator and outcome by,
Mi = 0.3Zi + εMi , Yi = 0.6Zi + 0.5Mi + εYi , (4.6)
where εMi
i.i.d.∼ N(0, 0.5), and εYi
i.i.d.∼ N(0, 0.5).
Table 4.1 reports the simulation results based on the above evaluation criteria.
Average bias and MSE decrease as the sample size n increases from 200 to 1000,
suggesting the accuracy of the estimates is improved with an increase of the sample
size. The coverage probability for both model parameters and causal effects are all
close to the nominal level 95.0%, ranging from 94.1% to 95.3%, indicating that the
standard errors are well estimated. Both ESE and ASE are close and decrease as
the sample size n increases, confirming the large-sample behaviours of the MLE. In
summary, the simulation results demonstrate clearly that the MLE provides accurate
estimation and appropriate statistical inference, even when the sample size is as low
as 200.
In our simulation study setting, the initial values {α̂(0) = 0, γ̂(0) = 0, β̂(0) =
0, σ̂
2(0)
M = v̂ar(M), σ̂
2(0)
Y = v̂ar(Y )} seem to be reasonable for the “optim” function to
search for the minimum. The “L-BFGS-B” algorithm does not fail even once to get
a convergent solution over 30,000 datasets. The associated computation cost is very
minimal and indeed negligible; a runtime of around 0.11 seconds is used to compute
a dataset with 500 subjects.
4.5.2 Simulation with Latent Exposure Model
For the latent exposure model (4.2), we first generate latent variable Zi from a normal
distribution with mean 0.5 and variance 1, followed by dichotomizing Zi into Xi = 1
if Zi > 0, or Xi = 0 otherwise. Then we generate mediator Mi and outcome Yi
according to regression models in (4.6). The latent exposure model (4.2) has one
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Table 4.1: Bias and MSE of parameter estimates and causal effects, and the coverage
of the 95% confidence interval for the effective dose model; the sample
size varies over 200, 500 and 1000, and the results are obtained by 10,000
replicates.
Bias (×10−3) MSE (×10−3) Coverage (%)
True 200 500 1000 200 500 1000 200 500 1000
α 0.30 -3.11 -0.76 -0.32 7.54 3.01 1.50 95.0 95.0 95.3
γ 0.60 -2.31 -1.27 -0.32 9.69 3.95 1.94 94.9 94.7 95.0
β 0.50 1.81 0.52 0.09 5.93 2.36 1.19 95.0 94.9 94.9
σ2M 0.50 -2.15 -0.79 -0.94 2.68 1.07 0.54 94.2 94.5 94.5
σ2Y 0.50 -6.14 -1.74 -1.02 3.13 1.29 0.64 94.1 94.5 95.0
GNDE 0.48 -1.84 -1.01 -0.25 6.17 2.51 1.24 94.9 94.7 95.0
GNIE 0.12 -1.78 -0.55 -0.30 1.35 0.53 0.26 94.8 95.1 95.0
ESE (×10−2) ASE (×10−2)
True 200 500 1000 200 500 1000
α 0.30 8.68 5.48 3.87 8.70 5.50 3.89
γ 0.60 9.84 6.28 4.41 9.78 6.19 4.37
β 0.50 7.70 4.86 3.45 7.67 4.85 3.43
σ2M 0.50 5.18 3.28 2.33 5.17 3.28 2.32
σ2Y 0.50 5.56 3.59 2.52 5.57 3.56 2.52
GNDE 0.48 7.85 5.01 3.52 7.81 4.94 3.49
GNIE 0.12 3.67 2.31 1.61 3.70 2.31 1.62
more parameter than the effective dose model (4.1), which is mean parameter µ set
at 0.5; the other five parameters are set the same as those given in Section 4.5.1.
Table 4.2 summarizes the simulation results based on 10,000 simulated datasets.
Average bias, MSE, ESE and ASE decrease as the sample size n increases, and the
coverage rate of 95% confident interval ranges from 93.8% to 95.4%, suggesting that
the inference procedure is appropriate. Once again, our moment-based initial values
appear reasonable to begin the “optim” function, as it is able to find the minimum in
all 30,000 datasets. The computation cost is very minimal with a runtime of around
0.3 minutes for a dataset of 500 subjects on a standard personal computer.
4.6 Data Application
We present a data application from the ELEMENT study described in the Section
of Introduction. The sample used in this mediation analysis is 368 mother-child
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Table 4.2: Bias and MSE of parameter estimates and causal effects, and the coverage
of the 95% confidence interval for the latent exposure model; the sample
size varies over 200, 500 and 1000, and the results are obtained by 10,000
replicates.
Bias (×10−3) MSE (×10−3) Coverage (%)
True 200 500 1000 200 500 1000 200 500 1000
α 0.30 -0.22 -0.71 -0.50 3.25 1.30 0.64 94.7 94.9 95.0
γ 0.60 -0.50 -0.05 -0.18 5.47 2.11 1.06 94.3 95.2 95.2
β 0.50 -2.63 -0.10 -0.16 8.04 3.19 1.57 94.8 94.9 94.8
µ 0.50 2.42 0.40 0.23 7.83 3.09 1.58 95.3 95.2 94.6
σ2M 0.50 -3.71 -0.92 -0.80 3.00 1.19 0.61 94.2 94.9 94.6
σ2Y 0.50 -8.38 -2.72 -1.21 4.65 1.86 0.94 93.8 94.3 94.7
GNDE 0.99 0.17 0.23 -0.13 14.36 5.52 2.79 94.5 95.2 95.4
GNIE 0.25 -3.75 -1.52 -0.93 3.03 1.19 0.57 94.0 94.5 94.7
ESE (×10−2) ASE (×10−2)
True 200 500 1000 200 500 1000
α 0.30 5.70 3.60 2.53 5.66 3.59 2.54
γ 0.60 7.39 4.59 3.26 7.28 4.61 3.26
β 0.50 8.97 5.65 3.96 8.84 5.57 3.94
µ 0.50 8.85 5.56 3.97 8.81 5.57 3.93
σ2m 0.50 5.47 3.45 2.47 5.49 3.48 2.46
σ2y 0.50 6.76 4.30 3.06 6.76 4.32 3.06
GNDE 0.99 11.98 7.43 5.28 11.90 7.52 5.32
GNIE 0.25 5.49 3.45 2.39 5.51 3.43 2.41
pairs. The study is a randomized control trial where 184 women are supplemented
with calcium (X = 1) and 184 women are supplemented with placebo (X = 0)
during pregnancy. The calcium supplement is administered to suppress the release
of the bone lead into the blood circulation during pregnancy (Perng et al., 2019). In
this way, prenatal lead exposure to offspring could be mitigated for the treatment
group. Young children absorb lead more easily than adults (Boeckx , 1986), and
exposure to lead can pose significant risks to offspring, such as preterm labor (Vigeh
et al., 2011), low birth weight (Zhu et al., 2010), and neurodevelopmental delays
(Vigeh et al., 2014). One study (Scholl et al., 2014) examined the relationships of
calcium metabolism and birth weight. Therefore we hypothesize that mitigating the
blood lead level by calcium supplementation , would affect birth weight in our study
population. In this analysis, exposure X is calcium supplement or not, mediator M
is mother’s blood lead level measured at third trimester, and outcome Y is offspring’s
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, where calciumi is the calcium baseline level measured at first
trimester. Therefore, the higher the baseline calcium level, the lower the absorption
rate ai during supplementation.
The blood lead level has three observations with negative values due to below
detection limit, and their values are changed to 0. The maximum value for blood
lead is 34.3 ug/dL with a mean of 4.3 ug/dL. The birth weight ranges from 1.9 kg to
4.2 kg, with a mean of 3.2 kg. The initial values are set at {α̂(0) = 0, γ̂(0) = 0, β̂(0) =
0, σ̂
2(0)
M = v̂ar(M) = 12.6, σ̂
2(0)
Y = v̂ar(Y ) = 0.16}. The mediator and outcome are
first centered to their respective means before the mediation analysis. In this way,
the intercepts are removed from the SEM.
Table 4.3 summarizes the estimates and 95% confidence intervals for both model
parameter and generalized causal effects. As expected, parameter α is estimated to
be negatively associated with the blood level, meaning that on average the treatment
group have a lower blood lead level. The CIs for both GNDE and GNIE contain 0 so
the causal effects are not significant. The estimates of γ and β are close to zero. In
conclusion, we do not have strong evidence from the data to support that there is a
significant generalized direct effect, nor a significant generalized indirect effect.
Table 4.3: Parameter and effect estimates and 95% confidence interval for the effect
of calcium supplementation on birth weight with potential mediator of
maternal blood lead at third trimester
Estimate SE 95% CI
α -0.2227 0.2342 (-0.6818, 0.2364)
γ 0.0050 0.0268 (-0.0476, 0.0575)
β 0.0013 0.0058 (-0.0101, 0.0127)
σ2M 12.6468 0.9394 (10.8057, 14.4880)
σ2Y 0.1558 0.0115 (0.1333, 0.1784)
GNDE 0.0055 0.0298 (-0.0529, 0.0639)
GNIE -0.0003 0.0015 (-0.0032, 0.0026)
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4.7 Concluding Remarks
This chapter develops a new framework of causal mediation analysis under the
structural equation models, in which mediator M and outcome Y are continuous and
normally distributed, and exposure X is binary. We present a useful extension of
the classical SEM framework by a latent exposure model for the binary exposure
under the premise that the “true” underlying dose of exposure is continuous and
latent. We propose two models: the effective dose model and latent exposure model
to characterize the mechanism as to how the binary exposure arises from a latent
continuum. The two models have different interpretations: the effective dose model
is suitable for a setting of the randomized control trial, while the latent exposure
model is applicable to the observational study, where binary exposure X is recorded
by dichotomization. We reestablish the concepts of direct and indirect effects under
the latent variable models and propose a generalization of NDE and NIE based on
changes of latent exposure Z. We showed that the generalized concepts offer more
interpretable causal effects. The simulation studies show that the MLE in both models
can achieve accurate estimates of parameter and causal mediation effects and provide




Chapter II developed a likelihood ratio test to jointly test for the mediation pathway
involving multiple correlated mediators. This is useful in practice to deal with a
cluster of mediators that often arise from studies with omics data. It has been shown
that the joint hypothesis testing method improves power over existing methods under
properly controlled type I error. This is a test method, along with the R package,
that we would like to recommended to practitioners.
Below are a few future directions of methodological development that further
extends the joint test.
(i) An extension of the current framework to the case of mediation pathway analysis
with binary outcome. When the logistic regression is used to a binary outcome,
the classical structural equation model becomes more complicated due to the
presence of nonlinear models (e.g. logistic model). Such deviation from the
linearity gives rise to substantial technical challenges that call for innovative
solutions. One major challenge pertains to the form of parametrization for
causal pathway, which is no longer the same expression of αβ in the classical
linear structural equation model. This extension may be carried out through
the generalized structural equation model (GSEM) proposed in Chapter III. We
plan to first extend the GSEM to accommodate multiple mediators and then to
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re-establish the likelihood ratio test under the constrained maximum likelihood
estimation or profile maximum likelihood estimation.
(ii) We plan to investigate some remedies that can alleviate the conservatism of type
I error for the case of α = β = 0. To do so, the key is to label this scenario from
the other two null scenarios, α = 0,β 6= 0 and α 6= 0,β = 0. The conservatism
is caused by different convergence rates for the test statistic in these three null
situations. One possible solution would be to invoke a certain parameter fusion
technique to identify these parameter groups. This relates to a simultaneous
operation of estimation and clustering, which may be solved by the means of
mixed integer programming.
(iii) An extension to the current framework is to add the extra terms for exposure
and mediator interactions, and solve the NIE under the null hypothesis. Other
future directions include investigating the influence of model mis-specification,
such as the effects of unobserved confounders.
Chapter III developed a unified framework of generalized structural equation mod-
els (GSEM) for mediation analysis with mixed data types. We established this frame-
work under one-dimensional exposure, one-dimensional mediator and one-dimensional
outcome. There are many future directions to extend this methodology. For example,
(i) an extended GSEM that accommodate multi-dimensional mediators. As pointed
out in Chapter II, handling multiple correlated mediators is a routine task in
practice, and there are no systematic methodologies to perform joint analyses of
such data of mixed types in the current literature. This extension can provide
a needed toolbox to practitioners with improved statistical power, so to obtain
new scientific findings.
(ii) An alternative formulation of GSEM may be considered via vine copulas. In
Chapter III, we adopted the Gaussian copula to formulate a DAG topology for
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the causal relationships. There are many other more flexible copula models,
such as vine copulas, that can improve the goodness-of-fit of GSEMs in the
analysis of data of mixed types. Naturally, there is a need of model selection;
which copula model to be chosen for the formulation of GSEMs.
(iii) Other useful extensions include allowing the interaction terms between exposure
and mediator, which are often encountered in practice; the influences of unob-
served latent confounding factors as well as the mis-specification of parametric
models.
Chapter IV developed two models that aim to characterize the underlying varia-
tion of personal exposure via the invocation of a latent exposure Z when the observed
exposure (treatment) is binary. We proposed new concepts of generalized NDE and
generalized NIE based on the latent exposure variable, which indeed give rise to better
interpretation of causal effects. For our short-term future work, we plan to continue
our methodological development in the following areas.
(i) We will incorporate confounding variables into both effective dose model and la-
tent exposure model, and update the maximum likelihood estimation procedure
in these expanded models.
(ii) We will develop a systematic approach to assess how different choices of distri-
butional assumption for Z may influence conclusions of statistical inference on
causal effects.
(iii) We will extend these two models in the framework of GSEMs developed in
Chapter III to perform mediation analysis with data of mixed types.
(iv) We will also allow the exposure-mediator interactions, and examine the influ-


































and Vn×(L+1) = (Z1, . . . ,ZL,X).
A.2 Proof of Lemma II.2
First, we prove the part (i) of Lemma II.2. Recall that



















Since H2(θ) is a diagonal matrix, and it has 2Q 1’s and (LQ+L+1) 0’s on diagonal,
implying that H2(θ) has 2Q nonzero eigenvalues equal to 1, and (LQ + L + 1) zero
eigenvalues. This shows that H(θ) has 2Q nonzero eigenvalues with their absolute
values being 1. Note that tr(H(θ)) = 0, implying h1 = · · · = hQ = 1, hQ+1 = · · · =
h2Q = −1.
Now let us prove the part (ii) of Lemma II.2. According to Theorem 1.4 in (Lu




2 has Q positive eigenvalues,
Q negative eigenvalues and the rest eigenvalues are zero, due to the fact that the
eigenvalues of I(θ)−
1
2 are all positive. Thus, the 2Q nonzero eigenvalues of A(θ),
υ1 ≥ υ2 ≥ · · · ≥ υQ > 0 > υQ+1 ≥ · · · ≥ υ2Q. Let I11 = 1nΣ
−1























































22 = C. We





The eigenvalues of A2(θ) are λ(A2(θ)) = (λ(CC>), λ(C>C)), where the non-









Q+1. In summary, A(θ) has 2Q nonzero eigenvalues in a descending
order υ1 ≥ υ2 ≥ · · · ≥ υQ > 0 > υQ+1 ≥ · · · ≥ υ2Q, satisfying
∑2Q
i=1 vi = tr(A(θ)) =
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0. This implies that υ1 = −υ2Q, υ2 = −υ2Q−1, . . . , υQ = −υQ+1. The proof is com-
pleted.
A.3 Proof of Lemma II.3
Let D = {Y,W,M,B} = {di}ni=1 denote all the observed data where di represents
the data from subject i. Let u(θ) =
∑n
i=1∇θ`(θ; di) denote the score function of
length 2Q + p, where p = LQ + L + 1, and let U(θ) = ∇θu(θ) be the Hessian




N{0, I(θ0)}. Moreover, by the Law of Large Number, − 1nU(θ0)
p→ I(θ0). Let {θ̃, λ̃}
be the solution of the Lagrange multiplier equation (2.3). Then, they satisfy the
following two equations:
u(θ) + nλḣ(θ) = 02Q+p, (A.1)
h(θ) = 0. (A.2)
It is straightforward to show that the k-th order (k ≥ 3) partial derivatives of h(θ)
are all zero for any θ. Taking the Taylor expansion on h(θ̃) in (A.2) around θ0,
h(θ̃) = h(θ0) + ḣ(θ0)
>(θ̃ − θ0) +
1
2
(θ̃ − θ0)>H(θ0)(θ̃ − θ0).
Since α = β = 0, h(θ0) = h(θ̃) = 0 and ḣ(θ0) = 02Q+p, then
(θ̃ − θ0)>H(θ0)(θ̃ − θ0) = 0. (A.3)
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On the other hand, taking the Taylor expansion of (A.1) around θ0 gives, subject to
a high order error term,
u(θ0) + U(θ0)(θ̃ − θ0) + nλ̃
{
ḣ(θ0) + H(θ0)(θ̃ − θ0)
}
≈ 02Q+p,





{U(θ0) + nλ̃H(θ0)}(θ̃ − θ0) ≈ −u(θ0).
Given that the matrix U(θ) + nλH(θ) is invertible for {θ, λ} in the small neighbor-
hood of {θ0, 0}, we have
(θ̃ − θ0) ≈ −{U(θ0) + nλ̃H(θ0)}−1u(θ0), (A.4)
√








This implies that for any λ∗ ∈ R, the conditional distribution of θ̃ given λ̃ = λ∗ is
[√




0, {I(θ0)− λ∗H(θ0)}−1I(θ0){I(θ0)− λ∗H(θ0)}−1
)
.
By plugging (A.4) into (A.3), we define
f(λ̃) = u(θ0)
>{U(θ0) + nλ̃H(θ0)}−1H(θ0){U(θ0) + nλ̃H(θ0)}−1u(θ0).
Taking derivative of f(λ̃) in λ̃ yields,
∂f(λ̃)
∂λ̃
= ḟ(λ̃) = −2nu(θ0)>{U(θ0) + nλ̃H(θ0)}−1H(θ0){U(θ0) + nλ̃H(θ0)}−1
H(θ0){U(θ0) + nλ̃H(θ0)}−1u(θ0).
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2 p→ A(θ). It fol-
lows that, as n→∞,
nf(0)

































similarly, we have as n→∞,
nḟ(0)







υ2q (ξq + ξq+Q),
with ξq




d→ Λ0, where Λ0
d≡ −
∑Q









i.i.d.∼ χ21, q = 1, · · · , 2Q. The proof is completed.
A.4 Proof of Theorem II.4
When α = β = 0, taking the Taylor expansion on {I(θ0)− λ̃H(θ0)}−1 around a small
neighborhood of λ̃ = 0, we have, subject to a high order error term,
{I(θ0)− λ̃H(θ0)}−1 ≈ {I(θ0)}−1 + λ̃I(θ0)−1H(θ0)I(θ0)−1.
It follows that
√




















n(θ̃ − θ̂) = λ̃I(θ0)−1H(θ0)I(θ0)−1 u(θ0)√n , we have
































d→ Λ0, where Λ0
d≡ −
∑Q



















d→ Λ1, where Λ1
d≡
[∑Q






q (ξq + ξq+Q)
,
with ξq
i.i.d.∼ χ21 for q = 1, . . . , 2Q. The proof is completed.
A.5 Additional Simulations
In this section, we include additional simulation scenarios, where exchangeable cor-
relations of mediators are set to 0.25 and 0, separately. Moreover, we also consider a
modified High-Dimensional Multiple Testing (HDMT) procedure for comparison(Dai
et al., 2020). HDMT was originally developed for a univariate screening of mediators
with controlled false discovery rate in genome studies, which is an approach widely
adopted in practice to avoid simultaneous inference. For the purpose of comparison,
we slightly added a decision rule to the method in a testing problem involving mul-
tiple mediators, described as follows. First, we calculate the adjusted p-values for Q
mediators using the HDMT method via the R package “HDMT”. Then, under the α0
significance level and α1 false discovery rate, we propose to reject the null hypothesis
if at least dQα1e number of adjusted p-values are less than α0. In this paper, we set
α0 = α1 = 0.05 in all comparisons considered in this paper.
The univariate screening HDMT method involves choosing the tuning parameter
λ ∈ (0, 1) related to the control of false discovery rate, which is preferably close
to 1(Dai et al., 2020). Thus, in this simulation study, we choose the default value
λ = 0.5 suggested in the R package “HDMT” and another value closer to 1, namely
λ = 0.9. It is evident that the HDMT test with λ = 0.5, 0.9 cannot give a proper
control of type I error. This may be due to the fact that the HDMT is developed
to screen high-dimensional mediators by the Benjamini-Hochberg procedure of false
discovery rate, which may not be suitable for a multi-dimensional simultaneous test
in the Neyman-Pearson hypothesis testing framework. Because of poor control of
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type I error by HDMT, this method will not be considered in the power comparison
below. Tables A.1, A.2 and A.3 show the type I error and power comparison when
the correlation among mediators are equal to 0.50, 0.25 and 0, respectively.
Table A.1: Empirical type I error under four null hypotheses, and power under four
alternative hypotheses with 10,000 replicates. The sample size varies from
200, 500, and 1,000. The exchangeable correlation of mediators is set with
correlation 0.5. Power increase (%) =
power of LR test
power of competing test
− 1.
n Method
Null Hypothesis Alternative Hypothesis Percent of power increase
i ii iii iv v vi vii viii v vi vii viii
LR 0.050 0.052 0.051 0.009 0.591 0.562 0.312 0.507 - - - -
PT-N 0.038 0.042 0.037 0.005 0.550 0.536 0.255 0.458 7.46% 4.78% 22.51% 10.72%
200 PT-NP 0.032 0.038 0.028 0.001 0.507 0.497 0.242 0.426 16.55% 13.07% 28.72% 19.20%
HDMT(λ = 0.5) 0.439 0.910 0.115 0.001 0.039 0.062 0.225 0.817 - - - -
HDMT(λ = 0.9) 0.934 1.000 0.787 0.018 0.251 0.344 0.633 0.991 - - - -
LR 0.046 0.049 0.045 0.007 0.970 0.954 0.648 0.928 - - - -
PT-N 0.041 0.045 0.039 0.005 0.967 0.953 0.624 0.922 0.30% 0.12% 3.78% 0.66%
500 PT-NP 0.038 0.044 0.035 0.001 0.962 0.947 0.620 0.916 0.78% 0.75% 4.5% 1.36%
HDMT(λ = 0.5) 0.961 1.000 0.767 0.002 0.059 0.066 0.599 1.000 - - - -
HDMT(λ = 0.9) 1.000 1.000 1.000 0.019 0.332 0.361 0.928 1.000 - - - -
LR 0.051 0.049 0.046 0.006 1.000 1.000 0.917 0.999 - - - -
PT-N 0.048 0.048 0.043 0.004 1.000 1.000 0.911 0.999 0.00% 0.00% 0.67% 0.01%
1000 PT-NP 0.046 0.049 0.041 0.000 1.000 1.000 0.910 0.998 0.00% 0.00% 0.71% 0.05%
HDMT(λ = 0.5) 1.000 1.000 1.000 0.001 0.064 0.071 0.907 1.000 - - - -
HDMT(λ = 0.9) 1.000 1.000 1.000 0.018 0.342 0.381 0.994 1.000 - - - -
Table A.2: Empirical type I error under four null hypotheses, and power under four
alternative hypotheses summarized over 10,000 replicates. The dimension
of mediators Q is 30. The sample size varies from 200, 500, and 1,000.
The exchangeable correlation among mediators is 0.25.
n Method
Null Hypothesis Alternative Hypothesis Percent of power increase
i ii iii iv i ii iii iv i ii iii iv
LR 0.045 0.048 0.049 0.009 0.573 0.519 0.402 0.475 - - - -
PT-N 0.034 0.038 0.037 0.005 0.536 0.497 0.340 0.433 6.84% 4.36% 18.18% 9.58%
200 PT-NP 0.027 0.034 0.031 0.001 0.498 0.460 0.320 0.402 15.17% 12.95% 25.55% 18.23%
HDMT(λ = 0.5) 0.049 0.609 0.390 0.002 0.033 0.028 0.156 0.812 - - - -
HDMT(λ = 0.9) 0.626 0.995 0.986 0.009 0.201 0.478 0.416 0.999 - - - -
LR 0.043 0.049 0.044 0.007 0.959 0.932 0.807 0.905 - - - -
PT-N 0.037 0.045 0.040 0.005 0.956 0.929 0.786 0.898 0.26% 0.3% 2.62% 0.78%
500 PT-NP 0.035 0.045 0.037 0.001 0.951 0.922 0.779 0.892 0.81% 1.07% 3.61% 1.4%
HDMT(λ = 0.5) 0.494 1.000 1.000 0.002 0.031 0.060 0.273 1.000 - - - -
HDMT(λ = 0.9) 0.963 1.000 1.000 0.008 0.458 0.690 0.655 1.000 - - - -
LR 0.050 0.048 0.046 0.006 1.000 0.999 0.983 0.997 - - - -
PT-N 0.047 0.047 0.043 0.004 1.000 0.998 0.982 0.997 0.00% 0.01% 0.17% 0.01%
1000 PT-NP 0.045 0.047 0.042 0.000 1.000 0.998 0.980 0.997 0.00% 0.01% 0.32% 0.06%
HDMT(λ = 0.5) 0.946 1.000 1.000 0.002 0.048 0.093 0.420 1.000 - - - -
HDMT(λ = 0.9) 0.999 1.000 1.000 0.010 0.634 0.741 0.854 1.000 - - - -
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Table A.3: Empirical type I error under four null hypotheses, and power under four
alternative hypotheses summarized over 10,000 replicates. The dimension
of mediators Q is 30. The sample size varies from 200, 500, and 1,000.
The exchangeable correlation among mediators is 0.
n Method
Null Hypothesis Alternative Hypothesis Percent of power increase
i ii iii iv i ii iii iv i ii iii iv
LR 0.042 0.044 0.060 0.009 0.536 0.478 0.475 0.288 - - - -
PT-N 0.032 0.036 0.044 0.005 0.505 0.457 0.406 0.249 6.04% 4.48% 16.87% 15.32%
200 PT-NP 0.023 0.031 0.040 0.001 0.469 0.426 0.379 0.242 14.13% 12.17% 25.16% 18.80%
HDMT(λ = 0.5) 0.023 0.872 0.785 0.004 0.113 0.130 0.137 0.939 - - - -
HDMT(λ = 0.9) 0.033 0.964 1.000 0.004 0.138 0.235 0.261 1.000 - - - -
LR 0.044 0.048 0.049 0.007 0.937 0.899 0.894 0.617 - - - -
PT-N 0.040 0.045 0.042 0.005 0.935 0.897 0.882 0.598 0.27% 0.30% 1.34% 3.13%
500 PT-NP 0.035 0.041 0.042 0.001 0.928 0.891 0.875 0.594 0.94% 0.91% 2.22% 3.86%
HDMT(λ = 0.5) 0.027 1.000 1.000 0.004 0.112 0.170 0.174 1.000 - - - -
HDMT(λ = 0.9) 0.039 1.000 1.000 0.005 0.138 0.316 0.316 1.000 - - - -
LR 0.050 0.046 0.046 0.006 0.999 0.996 0.997 0.898 - - - -
PT-N 0.048 0.044 0.044 0.004 0.999 0.996 0.996 0.894 0.00% 0.00% 0.06% 0.49%
1000 PT-NP 0.046 0.045 0.044 0.000 0.999 0.996 0.996 0.894 0.00% 0.04% 0.08% 0.45%
HDMT(λ = 0.5) 0.026 1.000 1.000 0.003 0.115 0.174 0.178 1.000 - - - -
HDMT(λ = 0.9) 0.037 1.000 1.000 0.004 0.140 0.311 0.319 1.000 - - - -
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APPENDIX B
Supplement for Chapter III





We know that Zx ∼ N(0, 1), Zm ∼ N(0, α2 + 1), and Zy ∼ N(0, η2 + β2 + 1), where
η = γ + βα. then it’s straightforward to obtain the covariances as follows,
cov(Zx, Zm) = cov(Zx, αZx + εx) = α
cov(Zx, Zy) = cov(Zx, γZx + βZm + εy)
= cov(Zx, γZx + β(αZx + εx) + εy)
= γ + βα
cov(Zm, Zy) = cov(αZx + εx, γZx + βZm + εy)
= cov(αZx + εx, γZx + β(αZx + εx) + εy)
= α(γ + βα) + β
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α α2 + 1 αη + β
η αη + β η2 + β2 + 1
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where η = γ + βα. The conditional distribution of any one or two variables from Zx,
Z∗m and Z
∗
y given the rest also follows the normal distribution. Next we will present
the details for parameter estimation for a single subject under the eight scenarios
where X, M and Y are discrete and continuous, respectively.
B.2 Joint density function of π(X,M, Y )
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where Zx = Φ
−1{Fx(X)}, Z∗m = Φ−1{Fm(M)}, and Z∗y = Φ−1{Fy(Y )}.
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where Zx = Φ
−1{Fx(X)}, Z∗m = Φ−1{Fm(M)}, ly = Φ−1(Fy(Y − 1)), and uy =
Φ−1(Fy(Y )).
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The joint distribution of Zx and Z
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(α− γβ)Zx + β
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(β2 + 1)(α2 + 1)
where Zx = Φ
−1{Fx(X)}, Z∗y = Φ−1{Fy(Y )}, lm = Φ−1(Fm(M − 1)), and um =
Φ−1(Fm(M)).





























y )I[X = F
−1
x {Φ(Zx)}]I[M = F−1m {Φ(Z∗m)}]×








y |Zx)π(Zx)I[Φ−1(Fm(M − 1)) ≤ Z∗m < Φ−1(Fm(M))]
I[Φ−1(Fy(Y − 1)) ≤ Z∗y < Φ−1(Fy(Y ))]dZmdZy
=π(Zx)P
(
Z∗m ∈ (lm, um), Z∗y ∈ (ly, uy)|Zx
)
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The joint distribution of Z∗m and Z
∗
y conditional on Zx is normally distributed with















































−1(Fy(Y − 1)), and uy = Φ−1(Fy(Y )).
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x {Φ(Zx)}]I[M = F−1m {Φ(Z∗m)}]×









Zx ∈ (lx, ux)|Z∗m, Z∗y
)
The joint distribution of Z∗m and Z
∗



































η2 + β2 + 1Z∗y



















α2 + γ2 + 1
where Z∗m = Φ
−1{Fm(M)}, Z∗y = Φ−1{Fy(Y )}, lx = Φ−1(Fx(X − 1)), and ux =
Φ−1(Fx(X)).
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y |Z∗m)π(Z∗m)I[Φ−1(Fx(X − 1)) ≤ Zx < Φ−1(Fx(X))]
I[Φ−1(Fy(Y − 1)) ≤ Z∗y < Φ−1(Fy(Y ))]dZxdZ∗y
=π(Z∗m)P
(
Zx ∈ (lx, ux), Z∗y ∈ (ly, uy)|Z∗m
)
The joint distribution of Zx and Z
∗
y conditional on Z
∗
m is normally distributed with











































where Z∗m = Φ
−1{Fx(X)}, lx = Φ−1(Fx(X − 1)), ux = Φ−1(Fx(X)), ly = Φ−1(Fy(Y −
1)), and uy = Φ
−1(Fy(Y )).
95





























y )I[X = F
−1
x {Φ(Zx)}]I[M = F−1m {Φ(Z∗m)}]×
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I[Φ−1(Fm(M − 1)) ≤ Z∗m < Φ−1(Fm(M))]dZxdZ∗m
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Zx ∈ (lx, ux), Z∗m ∈ (lm, um)|Z∗y
)
The joint distribution of Zx and Z
∗
m conditional on Z
∗
y is normally distributed with
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where Z∗y = Φ
−1{Fy(Y )}, lx = Φ−1(Fx(X−1)), ux = Φ−1(Fx(X)), lm = Φ−1(Fm(M−
1)), and um = Φ
−1(Fm(M)).
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y )I[X = F
−1
x {Φ(Zx)}]I[M = F−1m {Φ(Z∗m)}]×













−1(Fx(X − 1)) ≤ Zx < Φ−1(Fx(X))]×
I[Φ−1(Fm(M − 1)) ≤ Z∗m < Φ−1(Fm(M))]×
I[Φ−1(Fy(Y − 1)) ≤ Z∗y < Φ−1(Fy(Y ))]dZxdZ∗mdZ∗y
=P
(
Zx ∈ (lx, ux), Z∗m ∈ (lm, um), Z∗y ∈ (ly, uy)
)
where lx = Φ
−1(Fx(X − 1)), ux = Φ−1(Fx(X)), lm = Φ−1(Fm(M − 1)), um =
Φ−1(Fm(M)), ly = Φ
−1(Fy(Y − 1)), and uy = Φ−1(Fy(Y )).
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B.3 Effect calculation for E[Y (xa,M(xb)]

























y |Zx = zxa , Zm = zm)π(Z∗m|Zx = zxb)dZ∗ydZ∗m
























yP (ly ≤ Z∗y < uy|Zx = zxa , Zm = zm)π(Zm|Zx = zxb)dZm
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P (lm ≤ Z∗m < um|Zx = zxa)
dZ∗y















yP (ly ≤ Z∗y < uy|Zx = zxa , lm ≤ Z∗m < um)P (lm ≤ Z∗m < um|Zx = zxb)
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y |lxa ≤ Zx < uxa , Z∗m = z∗m)dZ∗yπ(z∗m|lxb ≤ Zx < uxb)dz∗m













yI(Fy(y − 1) ≤ Φ(Z∗y ) < Fy(y))|lxa ≤ Zx < uxa , Zm = zm
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×






yP ((Fy(y − 1) ≤ Φ(Z∗y ) < Fy(y))|lxa ≤ Zx < uxa , Zm = zm)×






yP (ly ≤ Z∗y < uy|lxa ≤ Zx < uxa , Zm = zm)π(Zm|lxb ≤ Zx < uxb)dZm
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y |lxa ≤ Zx < uxa , lm ≤ Z∗m < um)dZ∗y×
P (lm ≤ Z∗m < um|lxb ≤ Zx < uxb)















yP (ly ≤ Z∗y < uy|lxa ≤ Zx < uxa , lm ≤ Z∗m < um)×
P (lm ≤ Z∗m < um|lxb ≤ Zx < uxb)
B.4 Real Data
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Table B.1: NDE, NIE and TE estimates and 95 % CI obtained from GSEM for ELE-
MENT study. The breastfeeding duration was excluded from confounders.
Exposure Outcome NDE 95% CI NIE 95% CI TE 95% CI
MEHHP T2
glucose -0.013 (-0.121, 0.100) 0.017 (-0.002, 0.037) 0.004 (-0.107, 0.114)
C-peptide -0.101 (-0.220, 0.029) 0.013 (-0.003, 0.032) -0.088 (-0.212, 0.035)
MetS -0.065 (-0.132, 0.002) 0.016 (0.001, 0.026) -0.049 (-0.118, 0.017)
MEOHP T2
glucose -0.010 (-0.127, 0.099) 0.018 (-0.000, 0.037) 0.008 (-0.110, 0.116)
C-peptide -0.109 (-0.231, 0.012) 0.014 (-0.003, 0.033) -0.094 (-0.233, 0.027)
MetS -0.070 (-0.132, 0.008) 0.017 (0.001, 0.033) -0.052 (-0.115, 0.025)
MIBP T2
glucose 0.038 (-0.079, 0.147) 0.015 (-0.005, 0.047) 0.052 (-0.050, 0.168)
C-peptide -0.022 (-0.135, 0.090) 0.010 (-0.008, 0.038) -0.012 (-0.121, 0.103)
MetS -0.019 (-0.086, 0.050) 0.013 (-0.005, 0.038) -0.006 (-0.070, 0.069)
MEHHP T3
glucose 0.055 (-0.066, 0.166) 0.008 (-0.011, 0.022) 0.063 (-0.063, 0.173)
C-peptide 0.009 (-0.112, 0.129) 0.006 (-0.012, 0.019) 0.015 (-0.106, 0.135)
MetS 0.005 (-0.067, 0.075) 0.007 (-0.011, 0.018) 0.011 (-0.065, 0.081)
MEOHP T3
glucose 0.055 (-0.068, 0.181) 0.005 (-0.019 0.024) 0.061 (-0.062, 0.189)
C-peptide 0.024 (-0.104, 0.166) 0.004 (-0.014, 0.018) 0.028 (-0.099, 0.167)
MetS 0.008 (-0.069, 0.087) 0.005 (-0.016, 0.019) 0.013 (-0.064, 0.092)
MIBP T3
glucose 0.106 (-0.025, 0.253) 0.015 (-0.008, 0.045) 0.121 (-0.013, 0.269)
C-peptide 0.013 (-0.132, 0.165) 0.011 (-0.007, 0.038) 0.024 (-0.120, 0.176)
MetS -0.014 (-0.100, 0.081) 0.013 (-0.007, 0.036) -0.001 (-0.094, 0.103)
Table B.2: NDE, NIE and TE estimates and 95 % CI obtained from GSEM for boys
in ELEMENT study.
Exposure Outcome NDE 95% CI NIE 95% CI TE 95% CI
MEHHP T2
glucose -0.038 (-0.213, 0.123) 0.004 (-0.069, 0.033) -0.034 (-0.213, 0.124)
C-peptide -0.051 (-0.237, 0.156) 0.004 (-0.065, 0.034) -0.047 (-0.236, 0.152)
MetS -0.046 (-0.155, 0.084) 0.003 (-0.063, 0.024) -0.043 (-0.163, 0.079)
MEOHP T2
glucose -0.036 (-0.199, 0.126) 0.006 (-0.075, 0.037) -0.030 (-0.193, 0.132)
C-peptide -0.032 (-0.224, 0.201) 0.005 (-0.051, 0.043) -0.027 (-0.237, 0.191)
MetS -0.038 (-0.142, 0.076) 0.004 (-0.053, 0.033) -0.034 (-0.153, 0.088)
MIBP T2
glucose 0.001 (-0.136, 0.124) -0.008 (-0.045, 0.045) -0.008 (-0.148, 0.118)
C-peptide 0.030 (-0.130, 0.180) -0.007 (-0.050, 0.036) 0.023 (-0.141, 0.175)
MetS -0.002 (-0.096, 0.090) -0.007 (-0.040, 0.030) -0.009 (-0.106, 0.084)
MEHHP T3
glucose 0.030 (-0.092, 0.176) 0.005 (-0.065, 0.026) 0.035 (-0.099, 0.176)
C-peptide -0.064 (-0.239, 0.102) 0.007 (-0.035, 0.023) -0.057 (-0.238, 0.104)
MetS -0.029 (-0.114, 0.081) 0.009 (-0.030, 0.021) -0.020 (-0.113, 0.084)
MEOHP T3
glucose 0.025 (-0.107, 0.185) -0.001 (-0.072, 0.025) 0.025 (-0.115, 0.176)
C-peptide -0.030 (-0.189, 0.148) 0.003 (-0.056, 0.023) -0.027 (-0.193, 0.152)
MetS -0.019 (-0.114, 0.086) 0.005 (-0.043, 0.023) -0.014 (-0.118, 0.092)
MIBP T3
glucose 0.005 (-0.166, 0.174) 0.014 (-0.036, 0.062) 0.018 (-0.162, 0.182)
C-peptide -0.142 (-0.345, 0.075) 0.013 (-0.030, 0.060) -0.129 (-0.329, 0.082)
MetS -0.096 (-0.212, 0.007) 0.018 (-0.029, 0.054) -0.078 (-0.204, 0.023)
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Table B.3: NDE, NIE and TE estimates and 95 % CI obtained from GSEM for girls
in ELEMENT study.
Exposure Outcome NDE 95% CI NIE 95% CI TE 95% CI
MEHHP T2
glucose 0.042 (-0.127, 0.219) 0.017 (-0.007, 0.040) 0.059 (-0.117, 0.229)
C-peptide -0.092 (-0.263, 0.096) 0.023 (-0.007, 0.048) -0.069 (-0.256, 0.119)
MetS -0.043 (-0.139, 0.075) 0.020 (-0.011, 0.033) -0.023 (-0.126, 0.092)
MEOHP T2
glucose 0.048 (-0.142, 0.232) 0.018 (-0.016, 0.047) 0.066 (-0.131, 0.237)
C-peptide -0.115 (-0.298, 0.063) 0.025 (-0.011, 0.056) -0.090 (-0.277, 0.104)
MetS -0.053 (-0.157, 0.062) 0.022 (-0.004, 0.042) -0.031 (-0.142, 0.081)
MIBP T2
glucose 0.094 (-0.083, 0.272) 0.028 (-0.015, 0.106) 0.122 (-0.047, 0.295)
C-peptide -0.080 (-0.256, 0.102) 0.044 (-0.003, 0.118) -0.035 (-0.210, 0.138)
MetS –0.030 (-0.132, 0.077) 0.037 (0.001, 0.092) 0.006 (-0.092, 0.105)
MEHHP T3
glucose 0.109 (-0.089, 0.325) 0.006 (-0.042, 0.029) 0.114 (-0.075, 0.326)
C-peptide 0.148 (-0.017, 0.338) 0.007 (-0.046, 0.034) 0.155 (-0.015, 0.337)
MetS 0.072 (-0.031, 0.187) 0.006 (-0.033, 0.025) 0.078 (-0.030, 0.196)
MEOHP T3
glucose 0.116 (-0.101, 0.333) 0.005 (-0.045, 0.036) 0.121 (-0.103, 0.341)
C-peptide 0.143 (-0.064, 0.368) 0.006 (-0.049, 0.036) 0.149 (-0.061, 0.373)
MetS 0.070 (-0.054, 0.196) 0.005 (-0.035, 0.031) 0.075 (-0.064, 0.203)
MIBP T3
glucose 0.204 (-0.013, 0.448) 0.012 (-0.020, 0.065) 0.216 (-0.002, 0.452)
C-peptide 0.180 (-0.034, 0.414) 0.016 (-0.031, 0.085) 0.196 (-0.014, 0.422)
MetS 0.048 (-0.069, 0.182) 0.015 (-0.029, 0.058) 0.063 (-0.078, 0.202)
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APPENDIX C
Supplement for Chapter IV
C.1 NDE and NIE Derivations
C.1.1 Proposition IV.1
For Effective Dose Model (4.1), when X = 1 then Z > 0, then we have the following,






















. For the derivations




















E(Y |M,X = 1) =
∞∫
0




(γZ + βM)π(Z |M,X = 1)dZ
= βM + γE(Z |M,X = 1)












E(Y |M,X = 0) = E(Y |M,Z = 0) = βM,
E(M | X = 1) =
∞∫
0











E(M | X = 0) = 0.
Therefore, the NDE and NIE are given below,
NDE
=E{Y (1,M(0))} − E{Y (0,M(0))}














| X = 0
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=E{Y (1,M(1))} − E{Y (1,M(0))}

































{EM(A1 | X = 1)− EM(A1 | X = 0)} .
C.1.2 Proposition IV.2
For Latent Exposure Model (4.2), when Z > 0, we have X = 1 and the following,
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. For the remaining deriva-






































E(Y |M,X = 1) =
∞∫
0




(γZ + βM)π(Z |M,X = 1)dZ
= βM + γE(Z |M,X = 1)












E(Y |M,X = 0) = E(Y |M,Z = 0)
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Therefore, the NDE and NIE are given below,
NDE
=E{Y (1,M(0))} − E{Y (0,M(0))}



































EM(A2 + A3 | X = 0),
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NIE
=E{Y (1,M(1))} − E{Y (1,M(0))}
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